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Chapter 1 
General introduction 
 
 
 
 
1.1  Nanomaterials and safety concerns  
Nanotechnology is a multidisciplinary scientific field covering Physics, Engineering, Chemistry, and 
Biology sciences, which has brought a great revolution to our life. Due to their unique physicochemical and 
electrical properties, nano-sized materials have gained considerable traction in the electronics, biotechnology 
and aerospace engineering areas.[1] In the field of medicine, nanomaterials have been studied as a unique 
delivery carrier to realize the transfer of medicines, DNA, and molecules.[2],[3] Furthermore, nanomaterials 
(NPs) have been used as biosensors to monitor the quality and safety of the food and environment.[4–6] Except 
those, nanomaterials have been widely applied in our daily life, such as the food additives[7], cosmetics[8],[9], 
toothpaste[10], catalyst[11] and painting[12] and so on. With the wide applications of nanomaterials in our 
daily life, they have been regarded as safe materials for human’s life. However, nanomaterials could get access 
to human body through three main pathways: pulmonary, gastrointestinal, and dermal absorption.[13] 
nanomaterials suspended in the atmosphere could be inhaled through the airways and then transferred to the 
lung and finally cause damages to the lung and thereby corresponding sickness, especially for the workers who 
have a high probability to be exposed to the air environment full of nanomaterials. Figure 1.1 shows the 
potential side effects caused by nanomaterials, including the membrane leakage of lactate dehydrogenase, 
impaired mitochondrial function, apoptotic bodies, inflammation, chromosome condensation, as well as 
generation of reactive oxygen species (ROS) and DNA damage. Such studies have reported that the inhaled 
titanium oxide (TiO2) NPs causes pulmonary inflammation[14] and oxidative damages[15] to mice. What’s 
more, Song’ work reported that long term of exposure to nanomaterials is related to pleural effusion, pulmonary 
fibrosis and granuloma of human.[16] Besides that, nanomaterials could be transferred to the gastrointestinal 
tract through food and medicines and induce cytotoxicity.[17] Therefore, emerging application of 
nanotechnology has been threating human’s health. Meanwhile, studies on the safety of nanomaterials have 
come into being and been developed into a hot research field. It has been reported that nanomaterials induce 
cytotoxicity by generating ROS to damage the balance of oxidative stress and thus leading to DNA damage, 
apoptosis cytotoxicity, changes of cell mobility and cell signaling and cancer initiation.[18] Therefore, 
emerging application of nanomaterials in our daily life should be aroused concern due to cytotoxicity induced 
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by them. 
 
Figure 1.1 The cellular toxicity induced by nanomaterials with different characters. Exposure to 
nanomaterials with different parameters could potentially induce toxic side effects such as membrane leakage 
of lactate dehydrogenase, impaired mitochondrial function, inflammation, apoptosis, as well as chromosome 
condensation, generation of reactive oxygen species (ROS) and DNA damage.[19] 
1.2  Nanomaterials made of different substrates and relative toxicity 
To date, nanomaterials have been prepared from variety materials, such as metal and non-metal, polymeric 
materials and bioceramics. These different materials endowed nanomaterials with unique physicochemical 
properties and bio-contact surfaces, which lead to different cellular responses as displayed in figure 1.1. In this 
part, several representative nanoparticles were chosen and described as follows. 
1.2.1  TiO2 nanomaterials 
TiO2 is a simple inorganic compound and exists in four fundamental crystal forms: rutile (tegragonal), 
anatase (tetragonal), brookite (orthorhombic) and TiO2(B) (monoclinic). Rutile is the most stable phase at 
environmental pressure and temperatures, while anantase is more stable at nanometer dimensions.[20,21] 
Brookite is the rarest natural form of titanium dioxide, which is hard to produce in pure form. Brookite and 
rutile have the same color and luster. Its hardness and density are almost the same as those of rutile. TiO2(B) 
is less known than rutile, anatase and brookite, which was synthesized by Marchand[22] in 1980 and 
discovered in nature by Banfield[23] in 1991. 
General introduction 
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TiO2 is considered as a non-toxic compound due to its chemically inert properties. NPs composed with 
different ratios of rutile, anatase and brookite possess different physicochemical and surface properties. And 
TiO2 NPs have been widely produced and used in our daily life, such as the sunscreen, toothpaste, as well as 
catalysis and food additives. However, studies have shown that TiO2 NPs possess some toxic effects in vivo 
and in vitro studies, including ROS generation, DNA damage, genotoxicity as well as lung inflammation and 
live toxicity.[24–26] Besides that, TiO2 NPs were found gathered in the liver, lung, kidney, myocardium, as 
well as spleen and brains in the experimental animals, damaging the tissue functions and inducing 
sickness.[27–29] With the development of toxicity studies, more data about the mechanism of TiO2 NPs’ 
toxicity has been reported (figure 1.2), such as the ROS generated by the electron hole pairs, glutathione 
depletion and toxic oxidative stress induced by the photo-activity and redox properties, as well as the NPs-
mediated cell membrane disruption. 
 
 
Figure 1.2 The possible mechanism of cytotoxicity caused by TiO2 nanomaterials.[30] As shown above, 
the main reasons of cytotoxicity caused by TiO2 nanomaterials were based on the oxidation reaction on the 
nanomaterials’ surfaces. The electron hole-pairs caused by the movement of surface electrons induced the 
generation of ROS through the oxidation reaction of surface oxygen, which led to the oxidative stress and 
induced damages to the proteins, DNA and membrane injuries. Besides that, the photo-activity and redox 
properties of TiO2 nanomaterials caused inflammation and mitochondrial perturbation to cells through the 
glutathione depletion and toxic oxidative stresses. This process was generated based on the oxidation reaction 
of H2O2. Furthermore, the nanomaterials themselves could disrupt the cell membrane, leading to cell death and 
protein fibrillation. 
1.2.2  Aluminum oxide nanomaterials 
Aluminum oxide is a chemical compound of aluminum and oxygen with wear-resistant property and 
stable in acid and alkali. Due to its easily shaped character and high strength and stiffness, it has been applied 
in high temperature electrical insulators, high voltage insulators, thermometry sensors, wear pads, as well as 
ballistic armor and grinding media.[31] 
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It has been reported that aluminum-based NPs contribute 20% to all nano-sized chemicals with various 
application in the environment, such as fuel cells, polymers, paints, coatings, textiles, biomaterials and so 
on.[32] About their toxic effects, Lin et al.’s work reported that aluminum oxide NPs induced cell membrane 
depolarization and cytotoxicity to human lung epithelial cells A549. Besides that, Chen et al.[33] showed 
cytotoxicity of aluminum oxide nanoparticles by reducing cell viability, altering mitochondrial potential, 
increasing cellular oxidation, and decreasing tight junction protein expression of human brain microvascular 
endothelial cells in a dose- and time-responsive manner. For the plant toxicity, Burklew et al.[31] have reported 
that aluminum oxide nanoparticles adversely effected the growth and development of tobacco seedlings in a 
molecular level. Other toxic studies have reported the oxidative stress, genotoxicity, inflammation and other 
side biological effects. [34],[35] 
1.2.3  Gold nanomaterials 
Gold NPs (AuNPs) possess useful characters such as large surface-to-volume ratio, optoelectronic 
properties, as well as predominant biocompatibility, which make AuNPs an important tool in bio-
nanotechnology.[36] For example, the redox activity of AuNPs makes it used in the electronic devices and 
electrochemical sensing, and the surface-enhanced Raman scattering endows it the property of imaging and 
sensing.[37–40] AuNPs with different sizes could be controlled through different methods. Schmid et al.[41] 
showed that 1-2 nm of AuNPs could be prepared by reducing AuCl(PPh3) with diborane or sodium borohydride 
phosphine and capping reagents of phosphine. Besides that, the preparation of AuNPs with the size from 1.5 
to 5 nm could be achieved by biphasic reduction of HAuCl4 with sodium borohydride in the presence of thiol 
capping agents and alkanethiol capping agents.[42] As for the AuNPs of 10-150 nm, they could be prepared 
through reducing of HAuCl4 with sodium citrate in water with the capping agents of citrate.[43] Spherical 
AuNPs with the sizes from 1 to 100 nm generate a series of colors in aqueous solution and typically exhibit a 
size-relative absorption peak at 500-550 nm.[44] 
However, AuNPs have been reported to cause toxic effects both in vivo and in vitro experiment. Pan et 
al.[45] showed the size-dependent cytotoxicity of AuNPs with the range of sizes from 0.8 to 15 nm. Yen et 
al.[46] reported that AuNPs induced cytotoxicity and inflammation to J774 A1 murine macrophages by up 
regulating the expression of proinflammatory genes interlukin-1 (IL-1), IL-6, and tumor necrosis factor (TNF-
α). For the in vivo cytotoxicity, Cho et al. showed that PEG-coated AuNPs with the size of 13 nm caused acute 
toxicity and inflammation through intravenous administration to mice onefold at doses of 0.17, 0.85, and 4.26 
mg per kg. Except that, effects of AuNPs on cell functions have also been studied, such as the inhibition of cell 
migration, interference of cell differentiation, and so on.[47,48] 
1.2.4  Zinc oxide nanomaterials 
Nanomaterials produced from zinc oxide have been applied to paints, wave filters, sunscreens, UV 
detectors, gas sensors, as well as many personal care products.[49–53] With the increasing use in various fields, 
human exposure to zinc oxide (ZnO) NPs is extremely urgent to be studied.[54] The toxic study of ZnO NPs 
has been carried out on prokaryotic and eukaryotic systems. Reddy et al.[55] showed that ZnO NPs with the 
size of about 13 nm completely inhibited the growth of Escherichia coli (E. coli) at the concentrations over 
than 3.4 mM. While ZnO NPs at the concentration over than 1mM completely inhibited the growth of 
Staphylococcus aureus (S. aureus). In addition, Sharma et al.[56] reported the genotoxicity of ZnO NPs to 
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human epidermal cell line (A431) through damaging DNA and inducing oxidative stress even at low 
concentrations treatment. Furthermore, ZnO NPs released into the aquatic environment cause toxicity to the 
aquatic organism. Bai et al.[57] studied the effects of ZnO NPs (30 nm) on the zebrafish, showing the death of 
zebrafish embryos (50 and 100 mg/L) and retardation of the embryo hatching (1–25 mg/L) after 96 hours’ 
exposure. Except the in vitro study, the in vivo toxicity of ZnO NPs has also been carried on. Sharma et al.[58] 
showed the accumulation of ZnO NPs in the liver inducing cellular injury through oxidative stress and DNA 
damage after sub-acute oral exposure (300 mg/kg) for 14 consecutive days. 
1.2.5  Iron oxide nanomaterials 
Iron oxide nanomaterials with unique magnetic properties have been widely applied in biomedical, 
bioengineering and in vivo applications, such as the cellular labeling, molecular imaging, in vitro bioseparation, 
drug delivery, tissue repair, immunoassay, and hyperthermia treatment.[59–65] Although various 
modifications about the NPs have been done for improving the biocompatibility, their toxic potential is still a 
major concern. Naqvi et al.[66] showed that iron NPs with the size of 30 nm with the Tween 80 coating induced 
toxicity to murine macrophage (J774) cells after exposure of NPs at the concentrations of 300–500 μg/mL for 
6 hours. The death of cells was induced due to oxidative stress by generating ROS which damaged cells and 
caused cell death. Hussain et al.[67] reported that iron oxide NPs (30 and 47 nm) caused toxicity to rat liver 
derived cell line (BRL 3A) in a dose-dependent response. At higher levels exposure of NPs (100–250 μg/mL), 
the leakage of lactate dehydrogenase increased, but the glutathione decreased significantly. Besides that, the 
cell morphology became abnormal in size, showing cellular shrinkage, and irregular shape. 
1.2.6  Carbon nanomaterials 
Carbon nanomaterial is one of the most widely studied and used materials, including fullerene, endohedral 
fullerene and carbon nanotube. These carbon nanomaterials have been widely applied as the superconductor 
materials, optical devices, high-temperature superconductive materials, molecular switch, drug delivery as 
well as quantum computer and biomedical use.[68–72] The wide use of carbon nanomaterials will undoubtedly 
increase the risk of environmental exposure to human.[73] Muller et al.[74] studied the effects of multi-wall 
carbon nanotubes (CNT) or ground CNT on Sprague–Dawley rats through intratracheal administration (0.5, 2 
or 5 mg) for 60 days. The results showed that the CNT and ground CNT were accumulated in the lung with 
the ratio of 80% and 40% of the lowest dose. And inflammatory and fibrotic reaction were found after the 
treatment of both nanomaterials. Through the bio-dispersion study and TNF-α expression in the lung of CNT 
and ground CNT, the results suggest that CNT are potentially toxic to human. Besides that, Davoren et al.[75] 
studied the effect of single walled carbon nanotubes (SWCNT) on human lung cancer cell line (A549) cells. 
After exposure of SWCNT for 24 hours, the cellular viability was detected, displaying low acute toxicity. 
However, the adenylate kinase (AK) release and IL-8 indicated the damage of cell membrane integrity and an 
inflammatory response respectively. In case of carbon nanomaterials, the size, method of preparation as well 
as the presence of trace metals determine the degree of toxicity and biological response of the cells.[76,77] 
1.2.7  Silica nanomaterials  
The application of silica nanomaterials has many advantages in cell imaging, ultrasensitive single 
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bacterium detection, DNA and microarray detection, barcoding tags, separation and purification of biological 
molecules and cells, and drug delivery systems.[78–89] However, some studies have reported the side toxic 
effect of silica nanomaterials. Pasqua et al.[90] studied the cytotoxicity of kinds of silica nanomaterials: 
mesoporous nanomaterials (MCM-41, AP-T and MP-T) and spherical silica NPs, to human neuroblastoma 
(SK–N–SH) cells. The results showed that the cytotoxicity of silica nanomaterials increased in the order, 
MCM-41 < MP-T < AP-T ≈ SiO2, showing surface areas and shapes of NPs are important in the cytotoxicity 
of nanomaterials. In addition, Kim et al.[91] displayed the effects of commercial colloidal silica NPs in 
aqueous phase (LUDOX® silica NPs) with different sizes, stabilizer, and coating on the human neuronal cell 
line. The results showed the cytotoxicity increased in the order as LUDOX® CL (13.3 nm) < LUDOX® AS-
20 (16.9 nm) ≈ LUDOX® AM (15.3 nm). The ROS generation of silica AS-20 and AM after 48 hours’ exposure 
increased in a dose-dependent relationship and DNA-double strands were broken, showing the relationship 
between oxidative stress and cellular responses after exposure of silica NPs. Sizes of nanomaterials play a vital 
role in the cytotoxicity of nanomaterials. Li et al.[92] compared the potential cytotoxicity induced by 
amorphous silica particles with different sizes (498 nm, as well as 68, 43, and 19 nm). Human hepatoma 
(HepG2) cells were chosen to study the toxic effects of NPs after 24 hours’ treatment with 100 µg/mL of four 
silica NPs. The results showed that the smaller ones possessed higher toxicity. Besides that, ROS level also 
showed a size-dependent increase as the sizes of NPs became smaller, suggesting ROS generation as one 
possible damage pathway of the toxic effects caused by silica NPs. 
 
Figure 1.3 The endocytosis and exocytosis process of nanomaterials. The vehicle sizes of each different 
endocytosis pathways were various, which affect the cellular uptake ratios of nanomaterials. 
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1.3  Endocytosis and exocytosis of nanomaterials 
Nanomaterials that were exposed or injected to human body hold tremendous potential to cause damages 
and sickness to human. Understanding the mechanisms of nanomaterials’ endocytosis and exocytosis is crucial 
for safe and effective applications. Vesicle exocytosis releases content to mediate many biological events, and 
removal of nanomaterials from cells or human body, while endocytosis is of great importance for targeted 
targeting of nanomaterials for various applications. As shown in figure 1.3, nanomaterials went through 
endocytosis process to be internalized inside cytoplasm, and then the exocytosis to be cleared and transferred 
to extracellular environment. Decades of secreting cell studies have revealed that three exocytosis patterns are 
combined with three modes of endocytosis: (a) complete collapse fusion, in which vesicles collapse into the 
plasma membrane, and then classical endocytosis involving membrane invagination and vesicle remodeling; 
(b) kiss and run, which blends the pores to open and close; and (c) complex exocytosis, which involves the 
exocytosis of giant vesicles formed by vesicle-vesicle fusion, and then a large number of endocytosis, which 
takes the giant vesicles.[93,94] In general, endocytosis can be divided into two broad categories: phagocytosis 
(large particle uptake) and pinocytosis (uptake of fluids and solutes). Based on the proteins involved in 
different endocytic pathways as shown in figure 1.4, the pinocytosis is divided into clathrin-dependent and 
clathrin-independent endocytosis.[95] Furthermore, the clathrin-independent endocytosis is divided into 
caveolin-dependent, clathrin- and caveolin- independent endocytosis, as well as macropinocytosis. Here, the 
detailed information about each kind of endocytosis pathway will be introduced, which is important of the 
understanding of nanomaterials mediated cellular responses. 
 
Figure 1.4 Classification of endocytosis based on endocytosis proteins. The endocytosis firstly was 
divided into pinocytosis and phagocytosis. Following that, clathrin-dependent/independent endocytosis was 
separated from pinocytosis. After that, the detailed clathrin-independent endocytosis including caveolae-
dependent and caveolae- and clathrin-independent endocytosis, as well as macropinocytosis. 
Chapter 1 
14 
 
1.3.1  Clathrin-dependent endocytosis 
Clathrin-dependent endocytosis needs to recruit endocytic molecules into clathrin-coated pits with the 
sizes of about 100 nm. The detailed endocytic process was displayed in figure 1.5. Firstly, adaptor proteins, 
such as adaptor protein 2 (AP-2), combine with the cargo-bearing receptors to promote the clathrin assembly 
into a lattice-like network, and thereby initiate the formation of clathrin-coated pit.[96–98] Then, the clathrin-
coated vesicles were converted by the driving force of clathrin assembly into highly curved clathrin-coated 
pits.[99] After that, the clathrin and adaptor proteins coated on the pit were recycled to next clathrin-dependent 
endocytosis. Besides that, other endocytic regulatory proteins were also recruited to participant next 
endocytosis, such as dynamin and synaptojanin.[100] After that, the uncoated clathrin pits were transferred to 
the early endosomes for subsequent endocytic processes.[101] 
 
Figure 1.5 The mechanisms of clathrin-dependent endocytosis mediated by adaptor proteins, such as AP-
2. 
1.3.2  Macropinocytosis 
Macropinocytosis is signal-dependent and in response to growth factor stimulation, including epidermal 
growth factor (EGF), platelet-derived growth factor as well as tumor-promoting factor.[102–107] The 
macropinocytosis process was displayed in figure 1.6. Firstly, macropinocytosis involves the cytoskeleton 
rearrangement and membrane ruffling of the plasma membrane mediated by actin.[108–111] Most of the 
lamellipodia formed by actin will finally retract back to the cells, while part of lamellipodia may fold back 
onto itself and form large and irregularly shaped macrophages through fusing with the basement 
membrane.[112,113] Macropinosomes are different from other forms of endocytic vesicles, which are 
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heterogenous in size, usually with the diameter beyond 0.2 μm (larger than clathrin-mediated endosomes), and 
no apparent coat structures. Due to the large size of macropinosomes (up to 5 μm in diameter), they provide 
non-selective internalization of solute and membrane to cells, and are also early to be identified through some 
fluid phase markers, such as dextran and horseradish peroxidase.[114,115] 
 
Figure 1.6 The pathways of macropinocytosis.[97] As shown above, the micropinocytosis involves 
various procedures to complete the transfer of molecules or nanomaterials. Firstly, cytoskeleton based on actin 
was rearranged to form the membrane ruffling. After that, the actin structure folds back onto itself to form the 
vehicles which are released to the cytoplasm, called macropinosome with the diameter more than 0.2 µm. 
Following that, the mature macropinosomes are formed through the tabulation during early maturation. The 
mature ones are transferred to the late endosome/lysosome or recycled back to the plasma membrane. 
1.3.3  Exocytosis 
Nanomaterials through endocytosis process remained in the cytoplasm, which increased the likelihood of 
unintended acute or chronic toxicity. Therefore, study the exocytosis of nanomaterials played an important role 
in the safety study of nanomaterials. 
Internalized nanomaterials could be cleared from cells through exocytosis which is an active transport in 
which nanomaterials and molecules, such as proteins and neurotransmitters, were transported out of the cells 
through expelling them in an energy-dependent process.[116–118] In exocytosis, membrane-bound secretory 
vesicles were transferred to the plasma membrane, and through fusion, the contents (water-soluble molecules 
or nanomaterials) inside the vesicles were secreted into the extracellular environment, which plays vital roles 
in the cell-cell contraction.[119–121] Besides that, exocytosis is also one way to realize the recycle and refresh 
of membrane components, through which membrane proteins, such as ion channels and surface receptors, and 
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lipids, and other membrane proteins could be transferred to the plasma membrane. 
1.4  Cellular responses 
Nanomaterials could cause different cellular responses based on their parameters, including size, shape, 
surface morphology, surface charge, surface modification, aggregation, as well as components. Therefore, how 
to evaluate if nanoparticles were safe or not played vital role in the safe nanoparticle design. Some studies 
simply evaluate the safety of NPs from the view of low and high cell viability after co-culture with cells, which 
causes big problems to the future NPs design for safe usage. That is because high cell viability of NPs does 
not mean NPs are safe to be used and the safety of toxic NPs is possible to be improved. To solve these 
problems, NPs should be studies from the different parameters that affect different cellular receptors, cellular 
uptake pathways, and stimulated different signaling transduction and cellular response. Through these detailed 
information, we could track the effects of NPs in details after exposure to cells and detected their safety all-
roundly, and finally improve the NPs properties for safe usage in our daily life. Here, we will give an 
introduction about the cellular responses to nanomaterials. 
 
Figure 1.7 The process of exocytosis of nanomaterials. The endocytic nanomaterials were cleared from 
the cytoplasm trough the exocytosis which was realized through the fusion of endocytosis vehicles to the 
cytoplasm membrane. 
1.4.1  Cell proliferation 
The proliferation or quiescence of cells are controlled by relative signaling pathways which transfer 
cellular environmental information to G1 phase of the cell cycle. As shown in figure 1.8, the proliferation 
process through G1 phase is controlled by phospho-Rb (Ser780) (pRB) signaling proteins, which repress the 
activity of E2-factor (E2F) transcription factors in mitosis and quiescent cells. Signaling to the RB pathways 
is achieved mainly through the regulation of cyclins and cyclin-dependent kinases (CDK) inhibitors. In 
mammalian cells, D type cyclin was firstly induced to be analyzed by the mitogenic signals, which activated 
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the cyclin-D-dependent CDK4/6. After that, the E type cyclins were induced to activate CDK2. The 
cooperation of cyclin-D-CDK4/6 and cyclin-E-CDK2 phosphorylated RB family proteins, and thereby depress 
E2F family proteins to transcript E2F-target genes and promote G1/S transition. Besides that, the INK4 family 
proteins inhibited the expression of CDK4/6, while the p21 family proteins inhibited both CDk4/6 and CDK2. 
The balance between activation and repression of CDKs realized the controlling of RB family proteins and 
thereby G1/s transition and cell proliferation. Furthermore, more and more detection methods about cell 
proliferation have been created and developed. Following is the introduction of these detection methods (table 
1.1). 
 
Figure 1.8 G1 cell cycle control by the pRB pathway which realizes the control of cell proliferation 
through the inhibition of E2F families.[122]  
1.4.2  Cell apoptosis 
Apoptosis, a programmed cell death, is critical for various processes, such as the normal development and 
function of the immune system, cell turnover, as well as embryonic development and cell death.[138] 
Meanwhile, the regulation of apoptosis is strongly correlative with diseases in the body. When the balance 
between cell growth and cell death is disturbed, the dysfunction in tissue and respective organs will happen, 
such as neurodegenerative diseases[139], autoimmune disorders[140], and cancers[141]. That is because 
apoptosis can not only control cell number and tissue size, but also clear and discard the infected, damaged, or 
stress cells from the organism.[142] Signaling for apoptosis could be activated by multiple independent 
pathway, either from inside of cells or outside of cells, for example, by ligation of death receptors. The common 
signaling molecules and relative signal pathways were displayed in Table 1.2. Furthermore, the detection 
methods of apoptosis have been discovered and developed, over the decades. Here, we give an introduction of 
Chapter 1 
18 
 
these detection methods as displayed in table 1.3, and their advantages and disadvantages were also listed in 
the table. 
 
Table 1.1 The list of detection methods about cell proliferation. 
Detection methods Characters 
Bromodeoxyuridine[123,124]  
A thymidine analogue incorporated during the S phase of 
the cell cycle 
Ki67[125,126] 
demonstrating all phases of the cell cycle through a nuclear 
antigen expression, except G0 and early G1 phases, only applied 
to frozen tissue; 
Proliferating cell nuclear 
antigen[127,128] 
a nuclear antigen essential for DNA synthesis; may be 
interfered under different fixation conditions; 
MTT[129,130] 
insoluble in standard culture medium; an endpoint assay 
because the formed crystals during reduction must be dissolved 
in DMSO or isopropanol; 
Alamar Blue[131–133] 
Due to increased activity of the enzyme lactate 
dehydrogenase during proliferation; soluble in culture media 
and nontoxic; 
XTT[134,135] 
reduceing less efficiently and may need additional factors 
added 
WST-1[136] more sensitive, and faster color development 
ATP[137] 
Sensitive and suited to high-throughput cell proliferation 
assays and screening 
 
Table 1.2 The apoptotic signals and relative pathways. 
Signal molecule Apoptosis pathway 
Tumour necrosis factor receptors: 
Fas and TRAIL[143,144] 
initiate the extrinsic pathway; 
When stimuli occur as Fas combines with Fas-L, 
death complex recruiting Fas-associated death domain 
and pro-caspase-8, formation of the death-inducing 
signaling complex is initiated to activates caspase-8. 
Bcl-2 family[145,146] 
key regulators of apoptosis; 
Reduced Bcl-2 expression may promote apoptotic 
responses; apoptosis signaling was translocated to 
mitochondria, from which apoptosis can be initiated. 
Apaf-1 and cytochrome c 
[147,148] 
Apaf-1 recruit downstream executioners (caspases-3 
and caspase-7) when the core complex is formed and 
caspase-9 is activated. 
NF-κB[149,150] 
The apoptosis process was interfered by the 
induction of target genes which were induced by the 
activation of IKK/NF-κB signaling pathway. 
p53[151,152] 
Governing main apoptosis signaling that 
mitochondria receive in the intrinsic pathway of 
apoptosis. 
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Table 1.3 The detection methods of apoptosis and their advantages and disadvantages. 
 
 
1.5  Cell migration 
Cell migration is a complex biological process containing turnover of cell-matrix adhesion site, integrin-
focal adhesion kinase (FAK) signaling pathway, and the actin cytoskeleton that pulls the cells and direct cell 
migration. For cell migration, the signaling transduction from the outside environment to cytoplasm requires 
Detection methods Advantages Disadvantages 
Light Microscopy Reliable and inexpensive 
Lacking objectivity 
and reproducibility 
for quantitative 
detection; low 
sensitivity 
Electron Microscopy 
Providing wide 
information 
Time consuming and 
strenuosity, difficult 
for quantification 
Gel Electro-
phoresis[153–156] 
Conventional 
gel 
electrophoresis 
Easy, sensitive and 
quantitative; Precise 
determination of cell death 
and DNA damage; Higher 
sensitivity (Comet assay); 
Providing more specific 
information about DNA 
damage; More accessible 
and feasible 
Tedious process; 
risk of cell 
membrane damage 
to mislead the 
results; More 
precisely; 
Pulse field gel 
electrophoresis 
Field-inversion 
gel electro-
phoresis (FIGE) 
Single cell gel 
electrophoresis 
(SCGE) 
Flow Cytometry[157,158]   
Easy, rapid and accurate 
quantitation; 
Time consuming 
In situ-end labelling method[159,160]   
Identifiable at the 
molecular level; study of 
very early events of 
apoptosis; 
 
Immunohisto- 
chemistry 
[161–164] 
Caspases 3 
unique, direct and 
sensitive 
Time consuming 
P53 
Annexin V 
M30 
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integrins as an outside-in transductor to react with the outside stimuli, and thus activate downstream signal 
molecular FAK to further send signals to nuclei and thereby control cell migration.[165] Although many 
integrins can bind fibronectin, integrin beta 1 is the major fibronectin receptor on most cells.[166] That is one 
of the transmembrane receptors which communicate with the extracellular signals and transmit signaling from 
external environment to cytoplasm and control the cell adhesion, proliferation and migration, and so on.[167]-
[168] Besides that, integrin beta 1 trafficking could be achieved through the same endocytosis pathways[169] 
with those of nanomaterials, such as the clathrin-mediated endocytosis, caveolin-mediated endocytosis and 
micropinocytosis and so on. Trafficking in the endosomes is controlled by GTP-binding proteins of the RAB 
and ARF (ADP-ribosylation factor) families.[170] The endocytic integrin beta 1 was sorted from the early 
endosomes to be recycled to the plasma membrane or degraded in lysosomes. Integrin beta 1 trafficking back 
to the plasma membrane including two distinct pathways often referred to as short-loop (RAB4 dependent) 
and long-loop (RAB8 and RAB11 dependent) pathways.[171],[172] Besides that, endocytic of integrin beta 1 
can also be trafficked to through a degradative route, from the late endosomes and multivehicle bodies, and 
the lysosomes.[170] 
Furthermore, FAK is a member of a family of non-receptor protein-tyrosine kinases that regulates integrin 
and growth factor signaling pathways involved in cell migration, proliferation, and survival.[173] In addition, 
FAK is one of the first downstream signaling components to become activated by integrins, which plays a 
critical role in integrin signaling and is essential for focal adhesion (FA) reassembly.[174] pFAK (FAK 
autophosphorylation Y397 site) was required for the enhancements in adhesion strengthening and integrin-
binding responses.[175] To migrate, a cell first extends protrusions such as lamellipodia and filopodia, forms 
adhesions, and finally retracts its tail. The actin cytoskeleton plays a major role in this process.[176] pFAK 
modulates F-actin dynamics like actin cytoskeleton polymerization and lamellipodia protrusion, and loss of 
pFAK fails to maintain the integrity of bundled actin filaments.[177],[178] 
Therefore, cell migration of cells is a complex process, which not only needs surface receptors, such as 
integrins to transmit signaling from the extracellular environment to cytoplasm; but also the cooperation of 
FAK and F-action to regulate the signaling transduction and thereby control cell mobility. 
1.6  Aims of this work  
Nanotechnology is an interdisciplinary branch of science that integrates biology, physics, chemistry, and 
engineering, which enables the production of materials and devices with novel structures and unique physical 
and chemical properties. Furthermore, advances in medical science nanotechnology have led to the 
development of TiO2, silver, silica, and gold nanomaterials suitable for biomedical applications. TiO2 NPs were 
the earliest industrial products and are one of the most highly manufactured nanomaterials in the world, in 
accordance with the U.S. National Nanotechnology Initiative. TiO2 NPs have generated considerable interest 
for use in a variety of applications, such as drug delivery, diagnostics, imaging, sunscreens, catalysts, paints, 
and food additives. The widespread use of TiO2 NPs in daily life has led to the belief that they are generally 
safe and non-toxic. However, NPs can be incorporated in the human body through three main pathways: 
gastrointestinal, dermal, and pulmonary absorption. Once inside the body, NPs can stimulate the production of 
ROS, damage DNA, and ultimately induce apoptosis, cytotoxicity and affect cell mobility. Through the three 
main internalization pathways, the two most affected tissue organs are the liver and lung.  
Liver is the organ that detoxifies various metabolites and clears the toxics, such as NPs, from human body. 
However, there are still few residual NPs in the liver organs, which may induce side effects to liver cells. 
Therefore, doses of NPs were chosen and studied as one parameter of NPs. HepG2 cell, an epithelial human 
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liver cancer cell line, with adhesion characters was studied to find the relationship between low doses of NPs 
and cellular response. For cancer cells, NPs usually were used as medical carrier in the drug delivery system 
(DDS) to kill cancer cells and inhibit their proliferation and invasion. However, when decreasing the exposure 
doses of NPs, what will happen to cancer cells? We will introduce and study it in chapter 2. 
Besides that, NPs through the airway could directly contact with the lung and induce various side effects 
to lung cells. However, NPs with different sizes could be filtered and expelled by the lung barrier firstly. 
Therefore, sizes of NPs were chosen and studied to find the relationship between sizes and cellular responses. 
NCI-H292 cell, an epithelial lung cancer cell line, with the collective cell migration was chosen to study the 
changes of apoptosis and cell migration after exposure of NPs. We will give detailed introduce about the 
relative cellular responses in chapter 3 and 4 separately. 
Furthermore, how to evaluate if NPs are safe or not plays vital role in the safe nanoparticle design. As 
shown in figure 1.9, some toxicology studies simply evaluate NPs from the low and high cell viability after 
treatment with cells, which caused big problems to the future NPs design for safe usage. High cell viability of 
NPs is not equal to be safe and low cell viability of NPs is possible to be improved. To solve these problems, 
NPs should be studies from the different parameters which affected different cellular receptors, cellular uptake 
pathways, and stimulated different signaling transduction and cellular response. Through these detailed 
information, we could track the NPs after exposure to cells and detected their safety all-roundly, and finally 
improve the NPs properties for safe usage in our daily life. Therefore, my work chose two NPs parameters, 
sizes and doses, and focused on their effects on cellular responses in the aim of improve the safe usage of NPs. 
 
Figure 1.9 The strategies of this work. Traditional nanotoxicology methods accessed the safety of NPs 
based on the cell viabilities. High cell viabilities mean the safety usage of NPs, while low cell viabilities mean 
the toxicity of NPs. However, this kind of study method does not put forward the solutions to improve the 
safety of NPs. Therefore, to solve these problems, our work will study the safety of NPs by separating NPs 
based on different parameters and each different cellular response to precisely improve NPs properties for safe 
usage in our daily life. 
Chapter 1 
22 
 
1.6.1  Doses of TiO2 NPs and cellular proliferation 
The problem to be solved in this part of work is about the dose of TiO2 NPs. As shown in figure 1.10, to 
study the toxic effects of TiO2 NPs on cells, some studies just artificially increased the exposure doses of NPs 
to decrease the cell viabilities and cause cell death, through which to prove the cytotoxicity of NPs. However, 
these results could not reflect the real cytotoxic effects of NPs. That is because only few NPs could be 
internalized into human body in the real environment and deposit in human organs and finally contact with 
cells. Therefore, to know the real effects of NPs on cells, low doses of NPs were exposed to cells with the aim 
to explore different cellular responses. 
1.6.2  Size of TiO2 NPs and cellular apoptosis 
Size is a determinable parameter of NPs, which determines the ratio of surface and volume, cellular uptake 
pathways, as well as cytotoxicity. However, the references showed NPs with irregular, aggregated shape and 
sizes, which makes it hard to study the relationship between sizes and cytotoxicity, and thereby increase the 
difficulty to design NPs with suitable sizes based on previous work. Therefore, in this part work, TiO2 NPs 
with uniform shape and sizes were prepared to study the relationship between sizes and cytotoxicity (Figure 
1.11). Based on the relationship between size and cellular responses, more information was expected to be 
provide for future design of much safer NPs. 
 
Figure 1.10 The cell death caused by high doses of NPs and the unknown effects under low doses 
exposure of NPs. 
1.6.3  Size of TiO2 NPs and cell migration 
Cell migration plays vital roles on cancer invasion, cell proliferation and functions. And sizes determine 
how and how many NPs could be internalized to cells. To further study the sizes effects on cell mobility, cell 
migration was studied in this part to provide more information about the safety usage from the view of 
controlling cell migration. 
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Figure 1.11 The cellular effects of NPs with different sizes. NPs with different sizes could be internalized 
through different pathways, which are determinant to the cellular uptake ratios and thereby affect cellular 
responses. 
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2.1 Summary 
In this paper, we describe the effect of low concentrations of 100-nm polyethylene glycol–modified TiO2 
nanoparticles (TiO2-PEG NPs) on HepG2 hepatocellular carcinoma cells. Proliferation of HepG2 cells 
increased significantly when the cells were exposed to low doses (<100 µg/mL) of TiO2-PEG NPs. These 
results were further confirmed by cell counting experiments and cell cycle assays. Cellular uptake assays were 
performed to determine why HepG2 cells proliferate with low-dose exposure to TiO2-PEG NPs. The results 
showed that exposure to lower doses of NPs led to less cellular uptake, which in turn decreased cytotoxicity. 
We therefore hypothesized that TiO2-PEG NPs could affect the activity of hepatocyte growth factor receptors 
(HGFRs), which bind to hepatocyte growth factor and stimulate cell proliferation. The localization of HGFRs 
on the surface of the cell membrane was detected via immunofluorescence staining and confocal microscopy. 
The results showed that HGFRs aggregate after exposure to TiO2-PEG NPs. In conclusion, our results indicate 
that TiO2-PEG NPs have the potential to promote proliferation of HepG2 cells through HGFR aggregation and 
suggest that NPs not only exhibit cytotoxicity but also affect cellular responses. 
2.2 Introduction 
TiO2 NPs are utilized in a wide variety of industrial and consumer products, such as drug delivery systems, 
[1] antibacterial materials [2], cosmetics [3], sunscreens [3], electronics [4], and catalysts [5]. Consequently, 
various methods have been developed to prepare TiO2 NPs, including sol-gel techniques [6], hydrothermal 
methods [7], and solvothermal methods [8]. However, widespread use of TiO2 NPs has raised concerns about 
potential risks to human health, livestock, and the ecosystem due to long-term exposure and environmental 
release. [9] 
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In mammals, TiO2 NPs enter the body via gastrointestinal, dermal, or pulmonary absorption. The 
deposition mass of NPs is correlated with the exposure concentration. Koivisto et al. [10] found that the lung 
deposition mass increased though inhalation from 0.2 to 84.0 µg as the aerosol mass concentration increased 
from 0.8 to 28.5 mg/m3, showing a linear correlation with aerosol mass concentration. However, few NPs were 
deposited in the organs. Chen et al. [11] found that TiO2 NPs (80 nm) accumulated primarily in the liver of 
mice after oral administration, with a deposition mass of 3970±1670 ng/g. Another mouse study reported that 
the deposition mass of TiO2 NPs reached its highest level in the spleen, 1120 ± 880 ng/g, after intraperitoneal 
injection for 7 days [12]. These data suggest that it is more useful to study the effects of exposure to low doses 
of NPs at the cellular level. Many researchers have examined the cellular responses to exposure to high doses 
of NPs and found that high doses generate reactive oxygen species [13], damage DNA [14], and induce 
apoptosis [15, 16], inflammation [17], and differentiation [18]. The cellular responses to exposure to low doses 
of NPs remain unclear, however. 
PEG is generally considered as one safe polymer and is therefore widely utilized in medicine and 
biotechnology due to its unique properties, such as biocompatibility, ready excretion from living organisms, 
and resistance to protein adsorption. In our work, PEG was used for functionalization of the TiO2 surface to 
decrease the cytotoxicity of NPs. 
The aim of the present study was to characterize the cellular responses to exposure to low doses of TiO2-
PEG NPs. For this purpose, HepG2 hepatocellular carcinoma cells were used. TiO2-PEG NPs were 
characterized by scanning electron microscopy (SEM) and an electronic light scattering. Cellular responses 
were evaluated and analyzed with respect to surface modifications. Our results show that TiO2-PEG NPs 
stimulate the proliferation of HepG2 cells through the aggregation of hepatocyte growth factor receptors 
(HGFRs), thus providing important information that enhances our understanding of nanotoxicology. 
2.3 Materials and methods 
2.3.1 Cell culture 
HepG2 cells were cultured at 37oC and 5% CO2 in Dulbecco's modified Eagle medium (DMEM, high 
glucose, Nacalai Tesque, Japan) supplemented with 10% (v/v) heated fetal bovine serum (HFBS, Biowest, 
Japan), 100 µg/mL of penicillin, and 10 µg/mL of streptomycin (Nacalai Tesque, Inc. Kyoto, Japan). Cells 
were subcultured every 2 days. 
2.3.2 Synthesis of NPs 
TiO2 NPs were prepared as follows. Briefly, titanium (IV) oxide particles (anatase form containing rutile 
form) were purchased from Wako Pure Chemicals Industries (Osaka, Japan). Water-dispersed TiO2 particles 
were prepared by wet pulverization process under high pressure using NanomizerTM (NMS-200L, 
NANOMIZER Inc., Kanagawa, Japan). Twenty ml of 25 wt% of the TiO2 particles in water was passed through 
the generator of Nanomizer 10 times under 200 MPa pressure, then water-dispersed TiO2 particles were 
collected. The surface of TiO2 NPs was then coated with PEG co-polymer as previously described. [19] The 
water-dispersed TiO2 particles were mixed with PEG-maleic acid copolymer (AM1510K, Nihon Yushi Co., 
Ltd., Tokyo, Japan) modified with 4-amino-salicylic acid (Wako Pure Chemicals Industries). The final 
concentrations of these materials in dimethylformamide (DMF) were adjusted to 0.5 wt% of TiO2 and 1.5 
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mg/mL of polymer, respectively. Next, 20 mL of the mixture was incubated at 130oC for 16 h, followed by 
complete drying at 40oC for 10 min at a reduced pressure of 5 hPa. Thereafter, the TiO2-PEG NPs were re-
dispersed in sterilized water at a concentration of 1 wt%. The preparation process was displayed in figure 2.1. 
 
 
Figure 2.1 The preparation process and chemical structure changes of TiO2 and TiO2-PEG NPs during 
preparation processes. The R1 and R2 in the PEG coating was not shown because of the confidentiality. 
2.3.3 Cell viability assay 
The viability of HepG2 cells was assessed using a CellTiter-Glo® Luminescent Cell Viability Assay 
(Promega Corp., Madison, USA) according to the manufacturer’s instructions. HepG2 cells were seeded at a 
density of 1×104 cells/well in an opaque 96-well plate. After incubation at 37oC and 5% CO2 for 24 h, the cells 
were exposed to TiO2 and TiO2-PEG NPs at concentrations of 0, 10, 20, 40, 80, 100, 400, and 1000 µg/mL. At 
various times, the adenosine triphosphate (ATP) content of the cells was determined using a luminometer 
(TECAN, Tokyo, Japan) after adding an equal volume of CellTiter-Glo® reagent to each well. 
2.3.4 Cell counting using the Trypan blue method 
Nanomaterials may interfere with cell viability assays by light absorption, light scattering, or fluorescence. 
[20] To avoid or minimize NP-associated interference, cells were counted at various times using a disposable 
hemocytometer (Funakoshi, Tokyo, Japan). HepG2 cells were seeded at 1×105 cells/well in 24-well plates and 
incubated at 37oC and 5% CO2 for 24 h. The cells were then washed with phosphate buffered saline (PBS) 
once and exposed to 100 µg/mL of NPs for 12, 24, and 48 h. The cells were collected and stained with Trypan 
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blue to distinguish dead and live cells; living cells were counted using a hemocytometer. 
2.3.5 Cell cycle analysis 
HepG2 cells were seeded in 6-well plates at a density of 4×105 cells/well. After incubation for 24 h, TiO2 
and TiO2-PEG NPs were added to all wells except the control wells and incubated for 24 h. The cells were 
collected by trypsin treatment and then passed through a nylon mesh (Cell Strainer Snap Cap, Falcon, USA) 
to remove cell clumps. Subsequently, the cells were washed twice with PBS and fixed with 66% ethanol at 
4oC for 2 h, after which they were washed twice with PBS and stained with 200 µL of 1× propidium iodide 
(PI) and RNase staining solution (Propidium Iodide Flow Cytometry Kit for Cell Cycle Analysis, Abcam, 
Japan) and then incubated at 37oC for 20 min. Finally, DNA content was assessed using a SP6800 Spectral 
Analyzer with 488-nm laser illumination to determine the cell phase. 
2.3.6 Evaluation of cellular uptake by flow cytometry 
To avoid artifacts associated with dye modification of the size of NPs, we used original NPs not exposed 
to dye to assess cellular uptake by HepG2 cells and determine the percentage of cells containing NPs. [21] 
Briefly, 2 mL of a HepG2 cell suspension at a density of 5×105 cells/well was seeded in a 6-well plate and 
cultured for 24 h. The attached cells were exposed to TiO2 and TiO2-PEG NPs at 0, 100, 200, 400, 600, and 
800 µg/mL. Ultrasonic processing of the NP suspensions for 30 min before and after dilution was employed 
to ensure adequate dispersion. After 24 h of incubation, cells were trypsinized and passed through a nylon 
mesh (Cell Strainer Snap Cap) after washing twice with PBS to remove excess NPs. The cells were then 
collected by centrifugation and suspended in 1 mL of PBS with 6% HFBS. Subsequently, the cells were stained 
with 1 μL of 42 μM PI (dead cells) and 2 μL of 4.3 mM thiazole orange (all cells) (BD Cell Viability Kit, BD 
Biosciences, Becton, Dickinson and Co., CA). Finally, stained cells were detected using an SP6800 Spectral 
Analyzer (Sony Biotechnology Inc., Tokyo, Japan). Cell granularity was assessed using side-scattering (SSC) 
light, and cell size was assessed using forward scattering light (figure 2.2). 
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Figure 2.2 The detecting principles of cellular uptake of NPs by flow cytometer. When the incident lights 
hit on the surface of cells, one part of the incident lights moved forwardly, named as forward scatter; and the 
other part of incident lights were scattered, called as side scatter. From the forward scatter changes, the sizes 
of cells could be decided and gated. Meanwhile, the changes of side scatter show the granularity of cells, which 
could be applied to cellular uptake detection of NPs. 
2.3.7 Immunofluorescence and confocal laser scanning microscopy 
HepG2 cells were plated in a Cell view cell culture dish (Greiner Bio-One North America, Inc., USA) at 
a density of 2.5×104 cells/compartment and incubated for 24 h. Next, the cells were exposed to NPs at a 
concentration of 50 µg/mL and incubated for an additional 24 h, after which the cells were washed twice to 
remove excess NPs and then fixed with 4% paraformaldehyde (PFA) for 10 min. Subsequently, the cells were 
blocked with 1% bovine serum albumin (BSA)/10% normal goat serum/0.3 M glycine in PBS for 1 h, followed 
by washing three times (5 min each). Immediately after washing, the cells were incubated with anti–Met 
hepatocyte growth factor receptor (HGFR) antibody (1/100 dilution, EP1454Y, Abcam, USA) for 1 h at room 
temperature (RT) and then goat anti-rabbit IgG H&L (1/200 dilution, DyLight® 488, ab96883, Abcam, USA) 
in the dark for 1 h at RT. Both incubations were followed by washing three times (5 min each) with PBS. 
Confocal microscopy was performed using a confocal laser-scanning microscope (LSM510 META, Carl Zeiss 
Inc.). All images were acquired using a 63×1.4 Plan-Apochromat oil immersion objective. 
2.3.8 Statistical analysis 
All data were assessed for statistical significance using Student’s t-test. All values are presented as mean 
± SD (n≥3), *p≤0.05, **p≤0.01, ***P≤0.001 which is typically provided only in the figure legends. 
2.4 Results and discussion 
2.4.1 Characterization of TiO2 and TiO2-PEG NPs 
The morphology, size distribution, and dispersion of TiO2 and TiO2-PEG NPs in complete DMEM with 
10% HFBS (cDMEM) were characterized by scanning electron microscope (SEM), transmission electron 
microscope (TEM) and electronic light-scattering detector (ELS). The results are shown in figure 2.3. The 
SEM and TEM images indicated that the NPs were irregular and aggregated. The mean sizes of TiO2 and TiO2-
PEG NPs were measured as 186 and 130 nm respectively in cDMEM. Besides, the polydispersity index (PDI) 
values of TiO2 and TiO2-PEG NPs were accordingly 0.224 and 0.149. Obviously, PEG modification induced 
the dispersion of TiO2 NPs much easily and homogeneously. 
Generally, when NPs are dispersed in culture medium, protein molecules adsorb onto the surface, forming 
a corona [22, 23] that increases the mean size of the particles. However, surfaces covered with PEG resist 
protein adsorption due to the high steric exclusion of PEG. [24] In addition, PEG modification decreases the 
surface area/volume ratio and thus reduces the aggregation of NPs. Therefore, PEG modification was expected 
to reduce the tendency of TiO2-PEG NPs to aggregate. 
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Figure 2.3 Morphology and size distribution of TiO2 and TiO2-PEG NPs in complete cell culture medium. 
(A) SEM and TEM images of TiO2 and TiO2-PEG NPs; (B) size distributions of TiO2 and TiO2-PEG NPs;. 
Scale bar: 100 nm (SEM and middle TEM) and 2 nm (right TEM). 
2.4.2 Differences in cell viability at low and high NP dose 
To determine the number of viable cells, a homogeneous assay was performed based on quantitation of 
cellular ATP content. As shown in figure 2.4A, within 24 h, cell viability of TiO2-PEG NPs increased in a dose-
dependent manner from 100 to 150% at NP concentrations below 100 µg/mL. Cell viability decreased to 110% 
as the dose of TiO2-PEG NPs was increased to 1000 µg/mL. However, cell viability was still above 100%, 
indicating that TiO2-PEG NPs are not cytotoxic to HepG2 cells. The same trends were observed with an 
increase in incubation time to 48 h (figure 2.4B), with cell viability slightly higher compared with 24 h of 
incubation. For TiO2 NPs, within 24 h, cell viability kept around 100% even when the NPs concentration 
B 
A 
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increased to 1000 µg/mL. With the incubation time increasing, cell viability increased slightly. All in all, the 
cell viability results showed that TiO2 and TiO2-PEG NPs have no cytotoxicity to HepG2 cells. And cells 
exposed to TiO2-PEG NPs own higher cell viabilities. Based on the observed increase in cell viability, an NP 
concentration <100 µg/mL was defined as low doses, and correspondingly, concentrations ranging from 100 
to 1000 µg/mL were defined as high doses due to the observed decreases in cell viability. In addition, the 
viability of cells exposed to TiO2-PEG NPs was significantly higher than that of control cells not exposed to 
NPs. These results thus suggest that at low concentrations, TiO2-PEG NPs promote cell proliferation. 
Two different cell lines were examined in the viability assay, HepG2 and NCI-H292, although data are 
shown only for HepG2 cells. Only HepG2 cells exhibited significant proliferation, however. These results 
suggest that stimulation of proliferation is cell dependent. 
 
Figure 2.4 Growth of HepG2 cells after exposure to TiO2 and TiO2-PEG NPs for (A) 24 h and (B) 48 h. 
All values are presented as mean ± SD (n≥3). Data were analyzed using Student’s t-test; *p≤0.05, **p≤0.01. 
2.4.3 Low concentrations of TiO2-PEG NPs induced cell growth 
A cell counting assay was employed to verify the results of low-dose NP exposure. Live cells were stained 
with Trypan blue dye and counted. As shown in figure 2.5, the number of HepG2 cells exposed to the low 
doses of TiO2-PEG NPs (≤100 µg/mL) increased significantly at 12, 24, and 48 h compared with control cells 
not exposed to NPs. These results confirm that exposure to low doses of TiO2-PEG NPs promotes cell growth. 
TiO2 NPs did not increase cell numbers at 12 and 24 h compared with control cells not exposed to NPs. 
However, after 48 h incubation cells exposed to TiO2 NPs showed significant growth, while control cells 
reached the confluent stage at approximately 24 h. That is because cells exposed to NPs seemed to grow with 
cell aggregation and overlay (data not shown). The results suggested that NPs those were outside of cells, 
would connect cells and thus cause aggregation and overlay of cells. 
2.4.4 Low concentrations of TiO2-PEG NPs induced changes in the cell cycle 
To further examine the role of NPs in stimulating cell proliferation, we monitored the cell cycle by 
determining the DNA content of HepG2 cells using PI (a dye that stains nucleic acids) and flow cytometry 
analysis. As shown in Table 2.1, after exposure to TiO2-PEG NPs for 24 h, the DNA content of cells in the S 
phase increased significantly compared with control cells not exposed to NPs. However, for TiO2 NPs exposure 
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group, the DNA contents of cells in S phase showed no significant increase compared with control. This result 
confirms that TiO2-PEG NPs enhance the ability of HepG2 cells to proliferate. 
 
 
Figure 2.5 TiO2-PEG NPs induce proliferation of HepG2 cells. Cells were incubated without (white 
squares) or with TiO2 (black squares) and TiO2-PEG (gray squares) NPs at a concentration of 100 µg/mL for 
12, 24, and 48 h. All values are presented as mean ± SD (n≥3). Data were analyzed using Student’s t-test; 
*p≤0.05, **p≤0.01 
 
Table 2.1 Low doses of NPs induce DNA synthesis. HepG2 cells were incubated without (control) or 
with TiO2 and TiO2-PEG NPs at 100 µg/mL for 24 h. All values are presented as mean ± SD (n≥3). Data were 
analyzed using Student’s t-test; *p≤0.05, **p≤0.01 
 
Group/24 h 
Cell phases 
G0/G1 (%) S (%) G2/M (%) 
Control 55.45±1.93 25.15±0.47 19.40±1.46 
TiO2-PEG NPs 50.90±0.70 29.54±0.52* 19.56±0.18 
 TiO2 NPs 55.48±4.52 23.71±2.47 19.81±0.64 
 
2.4.5 Cellular uptake of TiO2 and TiO2-PEG NPs 
To elucidate the mechanism of cell growth promotion associated with exposure to low doses of TiO2-PEG 
NPs, cellular uptake of TiO2 and TiO2-PEG NPs was assessed by flow cytometry. As shown in figure 2.6A, 
compared with control cells, the SSC peaks of cells incubated with NPs shifted to the right, indicating NPs 
internalization. Figure 2.6B shows that the cellular uptake rate increased with increasing NPs dose. At NPs 
concentration of 100 µg/mL, the percentage of cells containing TiO2-PEG NPs was the lowest, at only about 
10%. The percentage of cells containing TiO2-PEG NPs increased to 60% at NPs concentration of 800 µg/mL, 
however. Furthermore, compared with that of TiO2 NPs, TiO2-PEG NPs showed a much lower incorporation 
of cells, as shown in figure 2.6B. The cellular uptake rate was therefore lower at low doses of TiO2-PEG NPs, 
which decreased the cytotoxicity of NPs. Accordingly, high doses of TiO2-PEG NPs stimulated a higher cellular 
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uptake rate, which resulted in higher cytotoxicity (figure 2.6C). 
 
 
 
Figure 2.6 Cellular uptake of TiO2 NPs and TiO2-PEG NPs. (A) Uptake rate of NPs by HepG2 cells. Cells 
were incubated without (open triangles) or with (closed squares) TiO2 and (open circles) TiO2-PEG NPs at a 
A 
C 
B 
C 
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concentration of 100 µg/mL for 24 h. (B) Percentage of HepG2 cells containing NPs. (C) The distribution of 
NPs at the extracellular and cytoplasm with the treatment of low and high dose of NPs: with high doses 
exposure, the intracellular NPs ratios were larger than those of extracellular NPs, which finally caused 
cytotoxicity; while with low doses exposure, the ratios of extracellular NPs were higher than those of 
intracellular NPs, which induced proliferation. Cells were incubated with TiO2 (closed squares) and TiO2-PEG 
NPs (open circles) at 0, 100, 200, 400, and 800 µg/mL for 24 h. All values are presented as mean ± SD (n≥3). 
Data were analyzed using Student’s t-test; *p≤0.05, **p≤0.01. 
2.4.6 TiO2-PEG NPs induced aggregation of HGFRs  
The receptor for hepatocyte growth factor/scatter factor (HGF/SF) is a transmembrane tyrosine kinase 
encoded by the c-MET oncogene, which is known to mediate mitogenic and invasive responses in several cell 
types. [25, 26] Recent research indicated that interactions between NPs and certain membrane receptors can 
promote aggregation of these receptors. [27] Therefore, we hypothesized that interaction of TiO2-PEG NPs 
with HGFRs would induce aggregation of HGFRs and subsequent proliferation of HepG2 cells, as shown in 
figure 2.7. To test this hypothesis, the localization of HGFRs was assessed by immunofluorescence staining 
using an anti-HGFR antibody. As shown in figure 2.8 (A and B), HGFRs were scattered on the surface of 
control cells not exposed to NPs. Weak HGFRs aggregations on the surface of cells with TiO2 NPs exposure 
group were observed in figure 2.8 (C and D). HGFRs aggregated on the surface of cells exposed to TiO2-PEG 
NPs (as shown by the arrow in figure 2.8F). These results confirmed that TiO2-PEG NPs exposure induces the 
aggregation of HGFRs in HepG2 cells, which in turn promotes cell proliferation. 
 
 
Figure 2.7 The hypothesis of cell proliferation through aggregation of HGFRs induced by TiO2-PEG NPs. 
HGFR is one transmembrane receptor of HepG2 cells. When cells are cultured in medium, the HGF in the 
medium could combine with the HGFR and activate its signaling pathway to control cell proliferation and 
differentiation, cell survival and apoptosis, as well as cell cycle G1/S checkpoint. With the exposure of NPs, 
the extracellular NPs may cause effects on the HGFRs and thus alter the signaling. Therefore, our work puts 
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forward a hypothesis that the extracellular NPs generate pressure to the cell membrane which leads to the 
location changes of HGFRs, such as aggregated HGFRs. Following that, the aggregated HGFRs recruit more 
signaling molecules to strongly stimulate the signaling pathways and finally improve cell proliferation. 
 
Figure 2.8 TiO2-PEG NPs induce the aggregation of hepatocyte growth factor receptors (HGFRs). Cells 
were incubated without or with TiO2 and TiO2-PEG NPs at 50 µg/mL for 24 h. Figure A and B: controls, 
without NPs exposure, the uniform distribution of the green fluorescence shows that HGFRs were scattered 
on the surface of cells; Figure C and D: TiO2 NPs exposure group: HGFRs were evenly scattered on the 
surface membrane of HepG2 cells; Figure E and F: TiO2-PEG exposure group: NPs induced HGFR 
aggregation, as shown by the arrow in Figure 2.8 F. Scale bar: 10 µm (Figure A, C, E) and 20 µm (Figure B, 
D, F). 
2.5 Discussion and conclusions 
In this work, the effect of TiO2-PEG NPs on HepG2 cells was examined. The low concentrations of NPs 
were defined as the less than 100 µg/mL of NPs in this work. The results of cell viability and cell counting 
assays confirmed that exposure to low doses (≤100 µg/mL), even 10 µg/mL, of TiO2-PEG NPs stimulates the 
proliferation of HepG2 cells. The significant increase in the DNA content of TiO2-PEG NP-exposed cells in 
the S phase also confirmed that exposure to low doses of TiO2-PEG NPs induces cell proliferation. To explore 
the mechanism of promoted cell proliferation at low doses of NPs, we evaluated the cellular uptake of NPs at 
different concentrations. The TiO2 and TiO2-PEG NPs were used as non-fluorescence-labeled NPs for cellular 
uptake experiments to avoid the changes of size and surface characterization after modification. Therefore, in 
our results, there could be no artificial effects of different fluorescence intensities of NPs on the cellular uptake. 
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We found that exposure to lower concentrations of TiO2-PEG NPs leads to lower rates of cellular uptake, which 
in turn decreases cytotoxicity. We also hypothesized that the observed increase in cell proliferation was related 
to a change in HGFR localization. Using immunofluorescence staining with an anti-HGFR antibody, we found 
that HGFRs aggregate on the surface of TiO2-PEG NP-exposed cells, confirming our hypothesis. Our results 
indicate that TiO2-PEG NPs induce the proliferation of HepG2 cells via promoting the aggregation of HGFRs 
and suggest that NPs exhibit not only cytotoxicity but also affect other cellular responses. We also investigated 
the same experiment using non-modified TiO2 NPs. TiO2-PEG NPs showed stronger effects that non-modified 
TiO2 NPs. The results suggested that both PEG-shell and TiO2 NPs themselves could be important for inducing 
cell proliferation by TiO2 NPs. PEG shell could change surface character and aggregation size of NPs. However, 
the PEG shell cannot completely cover the surface of NPs as the low coating density of PEG. Therefore, there 
are still proteins on the surface of NPs, which might affect induction of cell proliferation. 
Details regarding how TiO2-PEG NPs interact with HGFRs and induce cell proliferation remain unknown. 
NPs can interact with cell receptors either directly or indirectly. Specific effects of direct interaction between 
NPs and membrane receptors include inducing the receptors to aggregate. [27] Alternatively, the protein 
coronas of NPs can interact indirectly with cell membrane receptors. [28] Based on our work, we propose two 
hypotheses to explain TiO2-PEG NP-induced cell proliferation, as illustrated in figure 2.9. One hypothesis 
holds that insertion of TiO2-PEG NPs between the lipid bilayer changes the structure of the membrane, 
narrowing the space between HGFRs and leading to the formation of HGFR aggregates. The other hypothesis 
holds that TiO2-PEG NPs bind adjacent HGFRs together. These two hypotheses will guide our future efforts 
to elucidate the mechanism through which exposure to low doses of NPs induces cell proliferation. We 
understand that we did not fully explain this growth stimulation by NPs through HGFRs aggregation. So, we 
tried blocking or knock-down experiments of HGFRs. However, these blocking or knock-down of HGFRs 
induced slow proliferation, even without NPs. Therefore, we could not show direct evidence for this growth 
inhibition. 
 
Figure 2.9 Potential mechanisms of cell proliferation stimulated by TiO2-PEG NPs. One hypothesis holds 
that insertion of TiO2-PEG NPs between the lipid bilayer changes the structure of the cell membrane, narrowing 
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the space between HGFRs and leading to the formation of HGFR aggregates. The other hypothesis holds that 
TiO2-PEG NPs bind adjacent HGFRs together. 
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Chapter 3 
Uniform TiO2 nanoparticles induce apoptosis to epithelial cell line 
in a size-dependent manner 
 
 
 
 
3.1 Summary 
The size of TiO2 NPs is a vital parameter that determines their cytotoxicity. However, most reported 
studies have employed irregular shapes and sizes of TiO2 NPs, as it is difficult to produce NPs of suitable sizes 
for research. We produced good model TiO2 NPs of uniform shape and size for use in studying their cytotoxicity. 
In this work, spherical, uniform TiO2-PEG NPs of differing sizes (100, 200, and 300 nm) were prepared using 
the sol-gel method. A size-dependent decrease in cell viability was observed with increasing NPs’ size. 
Furthermore, apoptosis was found to be positively associated with NP size, as evidenced by an increase in 
caspase-3 activity with increasing nanoparticle size. Larger NPs exhibited higher cellular uptake, suggesting 
that larger NPs more strongly induce apoptosis. In addition, cellular uptake of different sizes of NPs was energy 
dependent, suggesting there are size-dependent uptake pathways. We found that 100- and 200-nm (but not 300-
nm) NPs were taken up via clathrin-mediated endocytosis. These results utilizing uniform NPs suggest that 
size-dependent cytotoxicity of NPs involves active cellular uptake, caspase-3 activation, and apoptosis in the 
epithelial cell line (NCI-H292). These findings will hopefully aid in the future design and safe use of NPs.  
3.2 Introduction 
Nanotechnology is an interdisciplinary branch of science that integrates biology, physics, chemistry, and 
engineering. Nanotechnology enables the production of materials and devices with novel structures and unique 
physical and chemical properties. [1] Furthermore, advances in medical science nanotechnology have led to 
the development of TiO2, silver, silica, and gold nanomaterials suitable for biomedical applications. TiO2 NPs 
were the earliest industrial products and are one of the most highly manufactured nanomaterials in the world, 
according to the U.S. National Nanotechnology Initiative. [2] TiO2 NPs have generated considerable interest 
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for use in a variety of applications, such as drug delivery, diagnostics, imaging, sunscreens, catalysts, paints, 
and food additives. [3-7] The widespread use of TiO2 NPs in daily life has led to the belief that they are 
generally safe and non-toxic. However, nanoparticles can be incorporated in the human body through three 
main pathways: gastrointestinal, dermal, and pulmonary absorption. Once inside the body, NPs can stimulate 
the production of reactive oxygen species (ROS), damage DNA, and ultimately induce apoptosis. [8-10] 
Therefore, designing suitable nanoparticles exhibiting a high degree of biocompatibility is critically important.  
Despite their widespread use, the TiO2 NPs typically used in research have some problems, such as 
irregular shape, large size range, and high potential for aggregation, all of which make it difficult to generate 
accurate data regarding nanoparticle safety for use in future development of NP applications. Size is a critical 
parameter affecting both the cellular uptake and cytotoxicity of NPs. Kim et al. [11] found that NPs ranging 
from 400 to 800 nm exhibit enhanced cytotoxicity resulting from ROS generation in response to oxidative 
stress. Furthermore, Andersson et al. [12] reported that both the primary size and agglomeration size of NPs 
play important roles in cytotoxicity through different cellular uptake pathways and pro-inflammatory responses. 
Therefore, controlling the size of NPs is particularly important for research examining their cytotoxicity. 
However, to date, no accurate data regarding size-associated differences in the safety of NPs have been 
reported. 
Here, we report the results of a study examining the size-dependent cytotoxicity of uniformly sized TiO2-
PEG NPs against NCI-H292 cells. The detailed strategies of this work were displayed in figure 3.1. The NPs 
were modified with PEG (a non-toxic, non-immunogenic FDA-approved polymer) to inhibit 
agglomeration.13,14 The shape and size of the NPs were controlled using the sol-gel method. The resulting NPs 
were uniform in shape and homogeneously dispersed in culture medium supplemented with 10% FBS, which 
was confirmed by SEM, TEM, and ELS analyses. Cells were exposed to NPs of different sizes to assess the 
effects on cell morphology, viability, apoptosis, and cellular uptake rate (energy-dependent or -independent). 
Finally, the relationship between the size of the uniform NPs and their cytotoxicity was evaluated, and the 
results confirmed that these NPs are good models for studies examining the effects of NP primary size on cells. 
 
 
Figure 3.1 The strategies of this part of work. Firstly, the problems on the aggregated sizes of NPs and 
their side effects to future studies were shown. Following that, to find the relationship between size and 
cytotoxicity, the good NPs model with uniform size and shape is needed in our work. The strategies show our 
schemes in this part of work, mainly including what the problems are and how to solve the problems. 
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3.3 Materials and methods 
3.3.1 Preparation of TiO2-PEG NPs 
Titanium (IV) dioxide spherical particles were kindly supplied by Fuji Kagaku Co., Ltd. (Osaka, Japan). 
The preparing method was as follows (figure 3.2). A 100-mL solution of 0.1 M titanium ethoxide in ethanol 
with 50% (v/v) acetonitrile was mixed and hydrolysed for 60 min at room temperature, with the addition of 
ammonium hydroxide in the final concentration range 0.01-0.1% (w/v), depending on the desired particle size 
(100, 200, or 300 nm). After hydrolysis, the mixed solution was heated at 80°C for 3 hours under reflux. The 
generated TiO2 spherical particles were then collected by centrifugation at 20,000g for 10 min and finally 
adjusted to 20% (w/v) with methanol. The crystalline phase of the TiO2 spherical particles was analysed using 
powder X-ray diffraction. No peak patterns were detected for any of the nanoparticles, so their crystalline 
phase appeared amorphous. The surface of the TiO2 spherical particles was then coated with PEG co-polymer 
as described in a previous report. [13] 
 
 
Figure 3.2 The preparation process of uniform TiO2-PEG NPs. Firstly, the uniform TiO2 NPs were 
prepared through sol-gel methods, then PEG was coated on the surface of TiO2 NPs to form a core-shell 
structure. 
3.3.2 Characterization of TiO2-PEG NPs 
For morphologic analysis, TiO2-PEG nanoparticles were dried using a Critical Point Dryer (Tousimis 931, 
USA) and then observed by SEM (Hitachi S-4800, Japan) and TEM (JEOL JEM 2100F, Japan). An ELS 
detector (Otsuka Electronics ELSZ-2000, Japan) was used to determine the size distribution, zeta potential, 
and PDIs of the various sizes of TiO2-PEG nanoparticles. For ELS characterization, nanoparticles (10 µg/mL) 
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were dispersed in water, RPMI-1640, or RPMI-1640+10% FBS to assess differences in nanoparticle 
aggregation. 
3.3.3 Cell culture 
NCI-H292 cells were cultured in RPMI-1640 medium (l-glutamine with Phenol Red, Nacalai Tesque, 
Japan) containing 10% (v/v) HFBS (Biowest, Japan), 100 µg/mL of penicillin, and 10 µg/mL of streptomycin 
(Nacalai Tesque, Japan). Cells were cultured in T75 flasks (ThermoFisher, USA) for mono-layer growth in a 
37°C/5% CO2 incubator. The cells were passaged once every 3 days using 0.05% trypsin - Ethylene diamine 
tetraacetic acid (EDTA) (Wako, Japan), which was inactivated by addition of complete cell culture medium. 
3.3.4 Cell viability and apoptosis assays 
The viability and apoptosis of NCI-H292 cells were assessed as follows. Briefly, 7.8×104 cells/mL of late 
log-phase NCI-H292 cells were seeded in 6-well culture plates (Costar, USA) and incubated for 24 h, after 
which the adherent cells were treated with nanoparticle solution when they reached 70-80% confluence (log 
phase). Before nanoparticle exposure, the cells were washed with 1×PBS (Sigma, USA) to remove secreted 
proteins on the cell surface that could bond with nanoparticles and result in their rapid sedimentation. TiO2-
PEG nanoparticles of different sizes were dispersed in complete culture medium at final concentrations of 10, 
40, 100, and 400 µg/mL. Next, 2.5 mL of nanoparticle solution was added to each well and incubated with the 
cells for 24 h. Finally, as many of the cells as possible were collected (including those floating in the culture 
medium and suspended in the washing PBS). The cells were then washed once with PBS and re-suspended in 
0.5 mL of 1× binding buffer. Soon afterwards, the cells were stained using annexin V-fluorescein 
isothiocyanate (FITC) (for detection of apoptotic cells) and ethidium homodimer III (EthD-III, for detection 
of necrotic cells) using an Apoptotic/Necrotic/Healthy Cells Detection kit (Promokin, Promocell, USA), 
according to the manufacturer’s instructions. After staining, the cells were washed twice with 1× binding buffer 
to remove excess EthD-III stain and fixed with 4% paraformaldehyde (PFA) solution for 10 min at room 
temperature. Finally, the cells were washed once and re-suspended with 1×binding buffer for flow cytometry 
(FACS, SP6800 Spectral Analyzer, Sony, Japan) analysis. 
3.3.5 Caspase-3 activity assay 
Apoptosis associated with nanoparticle exposure was assessed by monitoring the activity of caspase-3, a 
critical enzyme of apoptosis, using a caspase-3 assay kit (Sigma, USA). A total of 1×106 cells/well were seeded 
in 6-well cell culture plates (Costar, USA) and exposed to nanoparticles when the cells were 70-80% confluent. 
The adherent cells were then treated with 100 μg/mL of TiO2-PEG nanoparticles dispersed in complete cell 
culture medium. After incubation for 24 h, the cells were washed three times with 1×PBS (Sigma, USA) and 
collected by centrifugation at 600g for 5 min at 4°C. The cells were lysed using 1×lysis buffer, and caspase-3 
activity in the lysate was determined according to the kit manufacturer’s protocol. 
3.3.6 Cellular uptake assay 
Uptake of TiO2-PEG nanoparticles by NCI-H292 cells was assessed as described previously. [14] Briefly, 
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7.9×104 cells/mL were seeded in 6-well culture plates (Costar, USA) and cultured for 24 h. Adherent cells were 
then exposed to TiO2-PEG nanoparticles in solution at concentrations of 10, 40, 100, and 400 µg/mL. After 24 
h of incubation, the cells were washed three times, collected by centrifugation at 1200 rpm for 3 min, and 
dispersed in 1 mL of 6% HFBS/PBS solution. Before FACS analysis, the cells were stored on ice. Cell 
granularity was assessed using side-scattering light, and cell size was assessed using forward-scattering light. 
Cellular uptake was calculated based on changes in gated areas compared with control cells. 
Besides that, FITC labelled TiO2-PEG (FITC-TiO2-PEG) nanoparticles were employed to check the 
cellular uptake of nanoparticles. The NCI-H292 cells were treated with FITC-TiO2-PEG nanoparticles at a 
concentration of 100 µg/mL for 24 hours. After that, cells were stained with 4',6-diamidino-2-phenylindole 
(DAPI) (1/1000 [v/v], Dojindo, Japan) to localize the cells and observed by laser confocal microscope (Leica 
TCS SP5, Leica microsystems, Wetzlar, Germany) with a 63×1.4 Plan-Apochromat oil-immersion objective. 
3.3.7 Energy-dependent cellular uptake 
For flow cytometry assays, 2×105 cells/well were seeded in 6-well culture plates (Costar, USA) and 
incubated for 24 h. For the sucrose treatment group, 0.45 M sucrose solution was added to the culture and 
incubated at 4°C for 30 min; for the low-temperature treatment group, cells were pre-incubated at 4°C for 5 
min prior to exposure to nanoparticles; and for the control group, cells were kept in a 37°C incubator. The cells 
in each group were then treated with nanoparticles at 100 µg/mL for 2 h, after which they were collected for 
FACS analysis (the steps were the same as those described in above section 3.3.6). 
For laser confocal microscopy analyses, cells were seeded in a Cell-View cell culture dish (Greiner Bio-
One, USA) at a density of 5×104 cells/compartment and incubated overnight. The cells were then treated with 
0.45 M sucrose solution at 4°C for 30 min or pre-treated at 4°C for 5 min. Control cells were incubated at 
37°C. The cells were then exposed to FITC-TiO2-PEG nanoparticles at a concentration of 100 µg/mL for 2 h, 
after which the cells were stained and observed under a confocal microscope. The details of the analyses were 
as follows. First, the cells were washed three times with 1× PBS (Sigma) and fixed with 4% PFA (Wako, Japan) 
for 15 min at room temperature. The cytomembrane and nuclei of the cells were then stained separately using 
wheat germ agglutinin and Alexa Fluor® 594 conjugate (10 μg/mL, ThermoFisher, USA) for 10 min and DAPI 
(1/1000 [v/v], Dojindo, Japan) for 5 min at room temperature. Confocal microscopy was performed using a 
confocal laser-scanning microscope (LSM510 META, Germany). All images were acquired using a 63×1.4 
Plan-Apochromat oil-immersion objective. 
3.3.8 Statistical analysis 
All data were assessed for statistical significance using the Student’s t-test. All values are presented as 
mean±S.D. with at least 3 replicates (n≥3). *p≤0.05, **p≤0.01, ***p≤0.001, as indicated in the figure legends. 
3.4 Results and discussion 
3.4.1 Characterization of TiO2-PEG nanoparticles 
To accurately assess the effects of nanoparticle size on cells, spherical, uniform TiO2-PEG nanoparticles 
Uniform TiO2 nanoparticles induce apoptosis to epithelial cell line in a size-dependent manner 
57 
 
of different sizes were prepared using the sol-gel method. As shown in figure 3.3A, the upper panel of 
SEM figures show that the nanoparticles exhibited the basic spherical morphology of nanoparticles and were 
uniform in size and shape, which was also verified by the lower panel of TEM observations. Figure 3.3B shows 
the structure of TiO2-PEG nanoparticle modified by PEG copolymer through chemical bonds. Table 1 shows 
the size distribution, zeta potential, and polydispersity indexes (PDIs) of TiO2-PEG nanoparticles dispersed in 
water, RPMI-1640, and RPMI-1640 + 10% HFBS. From water to RPMI-1640 + 10% HFBS, the zeta potential 
changed from negative to almost neutral. The sizes of the nanoparticles were unchanged in water and RPMI-
1640 + 10% HFBS, but in RPMI-1640, the nanoparticles aggregated heavily, which was confirmed by the 
increase in PDI. These results show that TiO2-PEG nanoparticles are stable in suspension in the presence of 
10% HFBS, in agreement with the results of a previous study by Allouni et al. [15] on the stability of TiO2 
nanoparticles in RPMI 1640 containing FBS. 
Therefore, we prepared uniform TiO2-PEG nanoparticles with sizes of 100, 200, and 300 nm that were 
stable when dispersed in RPMI-1640 culture medium containing 10% HFBS, thus guaranteeing the ability to 
accurately assess the effects of nanoparticle size on cytotoxicity. 
  
 
  
Figure 3.3 Morphological characterization and structure diagram of TiO2-PEG nanoparticles of different 
sizes. TiO2-PEG nanoparticles 100, 200, and 300 nm in size were characterized by SEM (upper panels) and 
TEM (lower panels) in figure 3.3A. Both SEM and TEM images showed that the nanoparticles were spherical 
and uniform. SEM bar: 500 nm; TEM bar: 100 nm. The structure diagram of nanoparticles was displayed in 
figure 3.3B. PEG copolymer was modified on the surface of nanoparticle through chemical bonds to form a 
core-shell structure. The R1 and R2 were not shown in figure 3.3B because of the confidentiality. 
B 
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3.4.2 Size-dependent apoptosis induced by TiO2-PEG nanoparticles 
To investigate the effect of TiO2-PEG nanoparticle size on cytotoxicity, the following assays were carried 
out. First, the morphology of the cells exposed to TiO2-PEG nanoparticles was observed using optical 
microscopy, and the results are shown in figure 3.4A. As the nanoparticle size increased, the cells became 
smaller due to membrane damage. In addition, more cells grew in multilayers when exposed to 300-nm 
nanoparticles compared with cells exposed to 100-nm nanoparticles. Figure 3.4A shows that cells exposed to 
nanoparticles became apoptotic compared with control cells. Based on these results, cell viability and apoptosis 
assays were carried out using annexin V and EthD-III staining to examine changes in the cell membrane using 
flow cytometry. As shown in figure 3.4B, cells were separated into four quadrants in the quadrantal diagrams 
based on the annexin V and EthD-III staining results. The lower-left quadrant included healthy cells that were 
negative for annexin V/FITC binding (annexin V−) and EthD-III staining (EthD-III−); the lower-right quadrant 
included early apoptotic cells that were positive for annexin V/FITC binding (annexin V+) but negative for 
EthD-III staining (EthD-III−); the upper-right quadrant shows the late apoptotic cells that were annexin V+ 
and showed EthD-III uptake (EthD-III+); the upper left quadrant displays the necrotic cells which were annexin 
V−/ EthD-III+. From figure 3.4B, it can be clearly observed that the rate of apoptosis increased with increasing 
nanoparticle size. The viability and apoptosis rates of the cells in each quadrant were then determined and are 
displayed in figure 3.4C and 3.4D, respectively. The results of cell viability assays indicated that the 300-nm 
TiO2-PEG nanoparticles were the most cytotoxic, followed by the 200- and 100-nm TiO2-PEG nanoparticles, 
as shown in figure 3.4C. These results indicate that cell viability is dependent upon both the size and dose of 
TiO2-PEG nanoparticles. Accordingly, the apoptosis rate increased with increasing size and concentration of 
the nanoparticles (figure 3.4D). These results indicate that the nanoparticles employed in our work clearly 
demonstrate the positive relationship between nanoparticle size and apoptosis induction, with the larger 
nanoparticles inducing apoptosis at a higher rate, resulting in a decrease in cell viability. 
3.4.3 Size-dependent induction of caspase-3 activity by TiO2-PEG nanoparticles 
Caspase-3, an enzyme encoded by the CASP3 gene, is activated in apoptotic cells by both extrinsic and 
intrinsic signalling pathways [16] and is the primary ‘executioner’ protein in apoptotic cells. To further assess 
the relationship between nanoparticle size and cytotoxicity, apoptosis induced by TiO2-PEG nanoparticles was 
examined based on quantification of the p-nitroaniline (pNA) moiety released by caspase-3–mediated 
hydrolysis of acetyl-Asp-Glu-Val-Asp p-nitroanilide. The changes in caspase-3 activity induced by TiO2-PEG 
nanoparticles of various sizes are shown in figure 3.5. Compared with the control cells, which were not exposed 
to nanoparticles, the caspase-3 activity increased significantly following TiO2-PEG nanoparticle exposure and 
tended to increase with increasing nanoparticle size. In addition, the increase in caspase-3 activity in cells 
exposed to the 300-nm nanoparticles was significantly greater than that in cells exposed to the 100- and 200-
nm nanoparticles. These results demonstrate that the increase in caspase-3 activity is dependent on the size of 
the TiO2-PEG nanoparticles. 
A 
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Figure 3.4 Viability and apoptosis rate of NCI-H292 cells exposed to TiO2-PEG nanoparticles. Cells were 
exposed to three sizes of TiO2-PEG nanoparticles at concentrations of 0, 10, 40, 100, and 400 µg/mL. After 24 
h of exposure, the cell viability and apoptosis rate were determined by optical microscopy and FACS analysis. 
(A) Representative morphology of cells after 24 h of exposure to three sizes of nanoparticles at a concentration 
of 400 µg/mL. (B) Representative quadrantal diagrams of NCI-H292 cells exposed to three sizes of TiO2-PEG 
nanoparticles (400 µg/mL) for 24 h; apoptosis was assessed by measuring phosphatidylserine residues on the 
cell membrane, as shown in the right two quadrants. (C) Cell viability following exposure to three sizes of 
TiO2-PEG nanoparticles as determined by FACS analysis. (D) Apoptosis rate of cells exposed to three sizes of 
TiO2-PEG nanoparticles as calculated from the FACS results. Each independent experiment was repeated at 
least 3 times. All values are presented as mean±S.D. 
 
B 
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Figure 3.5 Effect of nanoparticle size on caspase-3 activity in NCI-H292 cells. Cells were exposed to 
three sizes of TiO2-PEG nanoparticles at a concentration of 100 µg/mL for 24 h. Caspase-3 activity in the cell 
lysate was then assayed using a caspase-3 kit (see Materials and Methods). Each independent experiment was 
repeated at least 3 times. All values are presented as mean±S.D. The significance of differences in the data was 
assessed using Student’s t-test. *Significantly different from control, *p≤0.05, **≤0.01, ***≤0.001. 
#Significantly different relative to lower sizes, #p≤0.05, ##p≤0.01. 
3.4.4 Effect of TiO2-PEG nanoparticle size on cellular uptake 
Cellular uptake of nanoparticles is closely associated with cellular responses such as apoptosis. In general, 
as cellular uptake of nanoparticles increases, cell viability declines and apoptosis increases. Therefore, cellular 
uptake of nanoparticles was analysed, and the results are shown in figure 3.6. As shown by the right-shifted 
curves in figure 3.6A (compared with the unexposed control cells), the nanoparticles were incorporated by the 
cells. In addition, the curves shifted further to the right as the nanoparticle concentration increased, indicating 
greater nanoparticle uptake. Figure 3.6B shows digitized cellular uptake curves that clearly demonstrate that 
cellular uptake of nanoparticles is size dependent. The 100-nm TiO2-PEG nanoparticles had the lowest cellular 
uptake rate, compared with the 200- and 300-nm TiO2-PEG nanoparticles. The cellular uptake of the TiO2-
PEG nanoparticles also differed based on the concentration. At the initial concentration, few 100-nm TiO2-
PEG nanoparticles were taken up by the cells, but the 200- and 300-nm TiO2-PEG nanoparticles exhibited 
about 40% and 90% uptake, respectively. As the nanoparticle concentration increased, cellular uptake of the 
200- and 300-nm nanoparticles did not change appreciably and demonstrated a saturation point at almost 100%. 
By contrast, the 100-nm nanoparticles were taken up much slower by the cells, eventually reaching an uptake 
maximum of about 80%. In addition, cellular uptake of FITC-TiO2-PEG nanoparticles also showed the diverse 
cellular distributions of nanoparticles with the changes of sizes, as shown in figure 3.6C. These results thus 
demonstrate that cellular uptake of nanoparticles is dependent upon both their size and concentration. Larger 
nanoparticles exhibit a much higher cellular uptake rate. 
To exclude the FITC coating effects on cellular uptake ratios, NPs without FITC coating were also 
exposure to cells for cellular uptake checking. The result showed that similar cellular uptake ratios no matter 
with or without FITC coating (data not shown). 
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Figure 3.6 Changes in uptake by NCI-H292 cells with increasing nanoparticle concentration and size. 
Cells were incubated with TiO2-PEG nanoparticles at concentrations of 10, 40, 100, and 400 µg/mL for 24 h. 
Cellular uptake of nanoparticles was calculated based on the side scatter parameter using FACS. (A) 
Histograms of cellular uptake of three sizes of nanoparticles. (B) Curves showing the change in cellular uptake 
with increasing size and concentration of nanoparticles. (C) Confocal microscope pictures show the cellular 
uptake of nanoparticles. The blue ones show the nuclei of cells stained by DAPI; the green ones show the 
FITC-TiO2-PEG nanoparticles as directed by the white arrows. Scare bar: 50 µm. Each independent experiment 
was repeated at least 3 times. All values are presented as mean±S.D. 
3.4.5 Energy-dependent cellular uptake of TiO2-PEG nanoparticle 
To determine whether the TiO2-PEG nanoparticle uptake process is active or passive, cells were incubated 
with nanoparticles at 37°C (control) or 4°C for 2 h. It is known that low temperature decreases the activity of 
several proteins and enzymes involved in active nanoparticle uptake. [17] As shown in figure 3.7A, uptake of 
all three sizes of TiO2-PEG nanoparticles was significantly lower at 4°C compared with that at 37°C. At 4°C, 
the average cellular uptake was reduced by approximately 50% for 100-nm nanoparticles, 60% for 200-nm 
nanoparticles, and 85% for 300-nm nanoparticles relative to uptake at 37°C. As shown in figure 3.7B, 
incubation at 4°C strongly depressed the uptake of all three sizes of TiO2-PEG nanoparticles, and few 
nanoparticles could be observed within the cells. Collectively, these results indicate that cellular internalization 
A 
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of TiO2-PEG nanoparticles is an active transport process involving energy consumption.  
Furthermore, several cellular pathways could be involved in the process of internalizing nanoparticles, 
such as phagocytosis and endocytosis. To further elucidate the mechanism of cellular uptake of TiO2-PEG 
nanoparticles, cells were incubated in hyperosmotic sucrose (0.45 M) to inhibit clathrin-mediated endocytosis. 
As demonstrated in figure 3.7A, the uptake of 100- and 200-nm nanoparticles by sucrose-treated cells was 
significantly lower than that of control cells, except for 300-nm nanoparticles. These results thus suggest that 
100- and 200-nm (but not 300-nm) nanoparticles are internalized via clathrin-mediated endocytosis.  
 
 
Figure 3.7 Energy-dependent cellular internalization of nanoparticles. Before exposure to nanoparticles, 
NCI-H292 cells were pre-treated at 4°C for 5 min or with 0.45 M sucrose inhibitor for 30 min. The cells were 
A 
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then exposed to nanoparticles at a concentration of 100 µg/mL for 2 h at 37°C (control, sucrose treatment) or 
4°C. Cellular uptake of nanoparticles was analysed by FACS (A) and observed by confocal microscopy (B). 
In figure 3.7B, green indicates nanoparticles, red indicates the cell membrane, and blue indicates nuclei. All 
values are presented as mean±S.D. (n≥3). The significance of differences in the data was assessed using 
Student’s t-test. *Significantly different from control. *p≤0.05. Scale bar: 20 µm. 
3.5 Discussion 
The relationship between the sizes of nanoparticles and their cytotoxicity has not been thoroughly 
elucidated. The key problem preventing the elucidation of this relationship is rooted in the non-uniform sizes 
of nanoparticles used in previous studies and their tendency to aggregate. Because of these issues, it has been 
difficult to define suitable size ranges for nanoparticles to be used in drug delivery and therapeutic agents. 
Therefore, the production of nanoparticles of uniform size and shape could increase their medical applicability 
by enabling accurate determinations of the relationship between nanoparticle size and biocompatibility. 
We prepared uniform, spherical TiO2-PEG nanoparticles and found that the rate of apoptosis increases 
with increasing nanoparticle size. We initially characterized the nanoparticles that we prepared and found that 
they exhibited good dispersity and homogeneous size in culture medium containing 10% HFBS. By contrast, 
the TiO2-PEG nanoparticles aggregated heavily when dispersed in culture medium without 10% HFBS. The 
stability of the nanoparticle suspension appeared to be primarily affected by inter-particle behaviours derived 
from inter-molecular and surface forces such as van der Waals interactions and the repulsive electrostatic 
double layer (EDL) and by structural forces such as depletion attraction. [18] In water, van der Waals 
interactions led to the aggregation of nanoparticles, whereas the steric repulsion induced by the PEG layer on 
the surface of the modified nanoparticles helped maintain the distance between the nanoparticles, thus 
decreasing the tendency toward aggregation. The increased mean size in water due to aggregation indicates 
that the effect of the van der Waals force is greater than that of steric repulsion, leading to slight aggregation. 
When dispersed in RPMI-1640 medium, the chemical properties of the nanoparticles were altered by the 
absorption of ions, thus decreasing the stability of the EDL and leading to the aggregation of the nanoparticles, 
which was confirmed by the increased zeta potentials and larger sizes. Therefore, in RPMI-1640 medium, 
more aggregation occurred than in water, resulting in larger-size TiO2-PEG nanoparticles. In RPMI-1640 
medium with 10% HFBS, however, the nanoparticles were enveloped by serum proteins which eventually 
formed a protein corona that increased their stability. Therefore, using this modification approach as the first 
step, we could prepare uniform TiO2-PEG nanoparticles exhibiting good dispersity.  
It has been reported that smaller-size nanoparticles are associated with higher cytotoxicity. [19-21] 
Interestingly, other reports indicate that smaller nanoparticles are associated with lower cytotoxicity. [22-23] 
However, these reported data were based on nanoparticles smaller than 100 nm. As reported by Horie et al., 
[24] larger nanoparticles have higher cellular uptake and induce higher rates of apoptosis and increases in 
intracellular ROS levels when the secondary particle size is greater than 100 nm. Cai et al. [25] demonstrated 
a size-dependent increase in cytotoxicity of TiO2 nanoparticles greater than 100 nm in size. We found that 200- 
and 300-nm nanoparticles were taken up at higher rates and exhibited higher caspase-3 activation and apoptosis 
induction than 100-nm nanoparticles.  
The development of nanoparticles of uniform shape and size would simplify the research parameters and 
provide more reliable data for subsequent design of nanoparticle applications. As reported here, we initially 
prepared nanoparticles exhibiting promising characteristics. These nanoparticles were then used to examine 
the effect of size on cytotoxicity, evaluated based on cell viability, apoptosis, and cellular uptake. Our results 
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clearly show that increasing the size of TiO2-PEG nanoparticles from 100 nm to 300 nm significantly affects 
cell viability, apoptosis, cell morphology, and cellular uptake.  
The mechanism of apoptosis induced by nanoparticles was also explored. Our results show that larger 
nanoparticles are taken up by cells at a higher rate, leading to an increase in apoptosis. As reported elsewhere, 
the size of delivered nanoparticles can have a major impact on their method of internalization and subsequent 
endocytic delivery. [26] Our data demonstrate energy-dependent cellular uptake via clathrin-mediated 
endocytosis for 100- and 200-nm nanoparticles, but 300-nm nanoparticles are primarily taken up via 
pinocytotic pathways. Therefore, size determines the cellular uptake pathway, which in turn affects the degree 
of cytotoxicity. However, as only a single cell line was used in the present study, we cannot exclude the 
possibility sensitivity differences [27] between cells. Therefore, more data are needed to fully elucidate the 
relationship between the size of TiO2-PEG nanoparticles and their cytotoxicity. 
3.6 Conclusions 
    As shown in figure 3.8, we demonstrated size-dependent induction of apoptosis of lung epithelial 
carcinoma cells (NCI-H292) following exposure to uniform TiO2-PEG nanoparticles. In addition, we proposed 
a possible mechanism by which differences in nanoparticle size affect endocytosis and cellular uptake rates 
and ultimately apoptosis. Collectively, our work could facilitate the production of uniform TiO2-PEG 
nanoparticles for use in a variety of future applications. 
 
 
Figure 3.8 Size-dependent increase in apoptosis induced by TiO2-PEG nanoparticles. Through energy-
dependent cellular uptake, TiO2-PEG nanoparticles of different sizes are incorporated into cells via different 
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cellular uptake pathways. Nanoparticles (100 nm): mainly clathrin-mediated endocytosis; nanoparticles (200 
nm): clathrin-mediated endocytosis and macro-pinocytosis; nanoparticles (300 nm): mainly macro-pinocytosis. 
After incorporation, nanoparticles induce a size-dependent increase caspase-3 activity, ultimately inducing a 
size-dependent increase in the rate of apoptosis. 
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4.1 Summary 
Nanoparticles (NPs) elicit various physiological responses in cellular environment, and the effect of NPs 
on cell migration is of high interest. In this work, the effects of NPs on cell migration and their possible 
mechanisms were studied. Here, we showed that after exposure to pegylated (polyethylene glycol, PEG) 
titanium dioxide nanoparticles (TiO2-PEG NPs), NCI-H292 cells exhibited slower migration than control cells. 
Furthermore, larger NPs produced a much stronger inhibition of cell migration than smaller NPs. Following 
NP exposure, the cells showed decreased expression of integrin beta 1 and phosphorylated focal adhesion 
kinase (pFAK), and disrupted F-actin structures. We demonstrated that a possible mechanism was through NP-
mediated promotion of the lysosomal degradation of integrin beta 1, thus leading to reduced expression of 
pFAK and cytoskeletal disruption and inhibited cell migration. Therefore, our results showed that NP-
inhibition of NCI-H292 cell migration is mediated through integrin beta 1, which provides useful information 
for the application of NPs in cancer therapy and other relative applications.  
 
4.2 Introduction 
Nanotechnology encompasses numerous, diverse research fields such as biology, engineering, chemistry 
and physics, among others. Furthermore, nanotechnology research has become integrated into many 
technological advances with wide applications in scientific, commercial and social fields. [1] All the while, 
nanomaterials continue to permeate our daily life and environment in the form of industrial, agricultural, 
medical, cosmetic and food products; a phenomenon that is accompanied by increased risk of exposure to 
diseases associated with nanomaterials. [2–6] It has been reported that nanomaterials can adversely affect cell 
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viability or physiology. [7,8] Furthermore, more insight is sought on the effects of nanomaterials on cells at 
the molecular level, such as the generation of reactive oxygen species after cellular uptake [9] and the resultant 
DNA damage [10,11], apoptosis and cell cycle arrest [12], cell skeletal disruption [13] and other effects. A 
deeper understanding of nano-bio interactions will provide more reference information for future efforts to 
develop safe designs for nanotechnology. 
Further, there is an immediate need to study the effects of nanomaterials on cell migration, which plays a 
significant role in determining embryonic development, wound healing, cancer progression, and immune 
responses. [14–17] To date, several studies have reported the inhibition of cell migration after nanomaterial 
exposure without clarifying the underlying mechanisms. [18,19] 
Cell migration is a complex biological process, involving turnover of cell-matrix adhesion sites, the integrin-
focal adhesion kinase (FAK) signaling pathway, and the actin cytoskeleton that pulls the cell and directs cell 
migration. For cell migration, signal transduction from the extracellular environment to the cytoplasm requires 
integrins as cell surface transducers that react with the extracellular stimuli, and thus activate the downstream 
signaling molecule FAK to further propagate the signal to the nuclei, which ultimately controls cell migration. 
[20] Although many integrins can bind fibronectin, integrin beta 1 is the major fibronectin receptor on most 
cells. [21] Integrin beta 1 is one of the transmembrane receptors that is activated by extracellular signals and 
transmits extracellular signals to the cytoplasm and controls cell adhesion, proliferation and migration, and so 
on. [22],[23] Additionally, integrin beta 1 and nanomaterials are trafficked through the same endocytosis 
pathways. [24] 
We hypothesized that integrin beta 1 is involved in nanomaterial endocytosis, as well as decreasing 
integrin-FAK signal transduction, thereby inhibiting cell migration. Understanding the molecular mechanisms 
of how nanomaterials interfere with cell migration will provide important information that will enable 
nanomaterial designs that lack such adverse effects and improve our general understanding of how 
nanomaterials affect cell migration. 
In this work, the effect of TiO2-PEG NPs on cell migration was studied. TiO2 NPs are commonly used in 
foods, cosmetics, toothpaste, medicines and other commercial products. [25–27] Here, PEG co-polymer was 
pegylated on the surface of TiO2 NPs to increase their hydrodispersity and biocompatibility. Human airway 
epithelial (NCI-H292) cells, which are derived from human non-small cell lung cancer (NSCLC) and exhibit 
collective migration, were chosen as a cell model to study the biological interactions between TiO2-PEG NPs 
and cells. Cell migration, cellular uptake, active integrin beta 1 expression and distribution, activated FAK 
activity and f-actin expression and structures were detected. We found that collective migration of NCI-H292 
cells was significantly inhibited in the presence of NPs. This could be attributed to NPs promoting lysosomal 
degradation of active integrin beta 1 receptor, decreasing expression of active integrin beta 1 and thus 
weakening the activated FAK signaling and disrupting f-actin structures that inhibit cell migration. Our novel 
findings provide a new perspective on how NPs affect cell migration. 
4.3 Materials and methods  
4.3.1 Cell culture 
 
NCI-H292 cells were cultured in RPMI-1640 culture medium (L-glutamine and Phenol Red) (Nacalai 
Tesque, Japan) supplemented with 10% (v/v) heat-inactivated Fetal bovine serum (FBS) (Biowest, France), 
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and 100 μg/mL of penicillin and 10 μg/mL of streptomycin (Nacalai Tesque). Cells were cultured at 37°C and 
5% CO2 in 100 mm culture dishes (Wako, Japan) and sub-cultured every 2 days. 
4.3.2 TiO2-PEG and FITC-labeled TiO2-PEG NP preparation 
TiO2-PEG NPs were prepared as previously described. [28] In brief, 0.1 M titanium ethoxide in ethanol 
was mixed with 50% (v/v) acetonitrile and hydrolyzed for 60 min at room temperature. Ammonium hydroxide 
was then added to form a hydrolysis solution. The final concentrations of ammonium hydroxide ranged from 
0.01 to 0.1% (w/v) and were dependent on the desired particle size. The hydrolysis solution was subsequently 
heated under reflux. The generated spherical TiO2 particles were then collected and finally adjusted to 20% 
(w/v) with methanol. Finally, a PEG co-polymer was coated on the surface of the spherical TiO2 NPs as 
described previously. [29] The morphology of NPs is displayed in Fig. S1 (supplemental information). 
Fluorescein isothiocyanate (FITC, Wako, Japan) was mixed with equivalent amounts of dopamine 
hydrochloride (DA, Wako, Japan) in 90% N,N-dimethylformamide/10% N,N-diisopropylethanolamine (v/v) 
for 1 hour at room temperature, and the reaction of the FITC-DA conjugate was monitored by thin layer 
chromatography on silica gel plates with n-butanol-acetic acid (10/90, v/v) as the mobile phase. For FITC 
labeling, 1 mM of the FITC-DA conjugate was gently mixed with 0.5 wt% TiO2-PEG NPs in an aqueous 
solution for 24 h at 4°C. After labeling, the aqueous solution of FITC-labeled TiO2-PEG NPs was washed, 
following centrifugation (20,000 g, 10 min), four times with sterile purified water (more than 99.99% of the 
solution was replaced) and re-dispersed. A detailed characterization of NPs is provided in our previous work. 
[28] 
4.3.3 Cell migration measurement 
To study the effects of TiO2-PEG NPs on cell migration, an in vitro scratch assay was performed according 
to the method described by Liang. [30] NCI-H292 cells were seeded in 6-well plates (Corning, USA) at a 
density of 8×104 cells/cm2 and cultured to a 100% confluent monolayer. Prior to seeding, two or three reference 
lines were created on the back of the 6-well plate using a syringe needle to mark the cell scratch locations for 
photographing. The scratches on the cell monolayer were then made using p200 pipet tips. A ruler was used to 
produce straight scratch lines. The distance between the edges of the scratches on the cell monolayer was 
quickly recorded using an optical microscope. The distances were measured using ImageJ 1.51 
(https://imagej.nih.gov/ij/download.html) and set as D0. The cells were then exposed to the TiO2 NPs (100, 
200 and 300 nm) at a concentration of 100 μg/mL for 3 h. The distances were then recorded as Dt. Based on 
changes in the width of the scratches, the cell migration index was calculated using the following equation. 
[31] 
 
Cell migration index (%) = (D0-Dt)/D0 × 100% 
4.3.4 Quantification of cellular uptake of TiO2-PEG NPs 
NCI-H292 cells were seeded in 6-well plates at a density of 4×104 cells/cm2 and cultured overnight to obtain 
approximately 80% confluence. The cells were then pre-treated with FITC-labeled TiO2-PEG NPs (100, 200 
and 300 nm) at a concentration of 100 μg/mL for 3 h. The cells were then washed thrice with 1×PBS to 
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completely remove NPs on the cell surface. The cells were then trypsinized, collected and re-suspended in an 
ice-cold 6% FBS/PBS solution to maintain cellular viability. Finally, the FITC intensity of the NPs was 
detected using a cell analyzer (SP6800, Sony, Japan) to evaluate differences in cellular uptake. 
4.3.5 Flow cytometry assessment of integrin beta 1, pFAK and F-actin 
NCI-H292 cells were seeded in 12-well plates (Corning, USA) at a density of 4×104 cells/cm2 and cultured 
overnight to allow adhesion. The culture medium was then replaced with fresh culture medium with or without 
TiO2-PEG NPs (100, 200 and 300 nm) at a concentration of 100 μg/mL for 3 h. The cells were then washed 
thrice with 1×PBS to completely remove residual NPs, trypsinized and collected by centrifugation at 1200 rpm 
for 3 min, and finally re-suspended in ice-cold 3% bovine serum albumin (BSA, Wako, Japan) solution for 
subsequent immunostaining. The cells were fixed by replacing the medium with 1% paraformaldehyde (PFA, 
Wako) for 10 min on ice, followed by replacement with 0.05% Triton X-100 (Wako) for 5 min on ice to 
permeabilize the cells. The pre-treated cells were then stained for f-actin with rhodamine phalloidin 
(Cytoskeleton, USA) or primary antibodies at a suitable concentration for at least 30 min on ice. The antibodies 
used in this study are as follows: phospho-FAK (Tyr397) antibody (31H5L17, Invitrogen, USA) and anti-
integrin beta 1 antibody [12G10] (ab30394, Abcam, USA); isotype control: rabbit IgG isotype control 
(Invitrogen) and mouse IgG (ab170190, Abcam). Negative controls were performed using the respective 
secondary antibodies only. Following primary antibody treatment, the cells were washed and stained with the 
secondary antibodies (donkey anti-Rabbit IgG (H+L) highly cross-adsorbed secondary antibody (Alexa Fluor 
488, Invitrogen) and goat anti-mouse IgG / IgM (H+L) secondary antibody (Alexa Fluor 488, Invitrogen)) for 
at least 30 min on ice in the dark. Following washing, the stained cells were re-suspended in 1% BSA solution 
for flow cytometer analysis (cell analyzer, SP6800, Sony, Japan). 
4.3.6 Immunofluorescent observation by confocal microscopy 
NCI-H292 cells were seeded in glass bottomed CELLview® cell culture dishes (Greiner Bio-one, 
Germany) at a density of 2.5×104 cells/cm2 and cultured overnight to allow adhesion. The culture medium was 
replaced with fresh culture medium with or without FITC-TiO2-PEG or TiO2-PEG NPs for 3 h. The cells were 
then washed completely and fixed with 4% PFA for 15 min and permeabilized using 0.1% Triton X-100 for 10 
min. The cells were subsequently blocked with 3% BSA for 40 min at room temperature and stained with 
phospho-FAK (Tyr397) antibody, anti-integrin beta 1 antibody [12G10], anti-EEA1 antibody - Early 
Endosome Marker (ab2900, Abcam) and anti-LAMP1 antibody (ab24170, Abcam) at 4°C overnight. After 
washing, cells were stained with the above secondary antibodies and rhodamine phalloidin for 1 h, or 4',6-
diamidino-2-phenylindole (DAPI, Dojin, Japan) for 5 min, at room temperature. Finally, the stained cells were 
mounted using anti-fade mounting solution (Fluoromount, Diagnostic Biosystems, Canada) and observed 
using a confocal microscope (Leica TCS SP5, Germany) with an oil 63 × 1.4 Plan-Apochromat oil-immersion 
objective. 
After confocal observation, the lysosomal integrin beta 1 was quantified. For control, the ratio of 
lysosomal integrin beta 1 was counted and calculated based on equation 1. After NPs exposure, to study the 
effects of NPs on the changes of lysosomal integrin beta 1, the ratio of lysosomal integrin beta 1 was counted 
and assed using equation 2. For each counting, five cells were selected. 
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𝑅𝑎𝑡𝑖𝑜 𝑜𝑓 𝑙𝑦𝑠𝑜𝑠𝑜𝑚𝑎𝑙 𝑖𝑛𝑡𝑒𝑔𝑟𝑖𝑛 𝑏𝑒𝑡𝑎 1 =  
𝑁𝑢𝑚𝑏𝑒𝑟𝑠 𝑜𝑓 𝑙𝑦𝑠𝑜𝑠𝑜𝑚𝑎𝑙 𝑖𝑛𝑡𝑒𝑔𝑟𝑖𝑛 𝑏𝑒𝑡𝑎 1
𝑁𝑢𝑚𝑏𝑒𝑟𝑠 𝑜𝑓 𝑙𝑦𝑠𝑜𝑠𝑜𝑚𝑒𝑠
× 100% (1) 
 
𝑅𝑎𝑡𝑖𝑜 𝑜𝑓 𝑙𝑦𝑠𝑜𝑠𝑚𝑎𝑙 𝑖𝑛𝑡𝑒𝑔𝑟𝑖𝑛 𝑏𝑒𝑡𝑎 1 =  
𝑁𝑢𝑚𝑏𝑒𝑟𝑠 𝑜𝑓 𝑙𝑦𝑠𝑜𝑠𝑜𝑚𝑎𝑙 𝑖𝑛𝑡𝑒𝑔𝑟𝑖𝑛 𝑏𝑒𝑡𝑎 1 𝑤𝑖𝑡ℎ 𝑁𝑃𝑠
𝑁𝑢𝑚𝑏𝑒𝑟𝑠 𝑜𝑓 𝑙𝑦𝑠𝑜𝑠𝑜𝑚𝑎𝑙 𝑁𝑃𝑠
× 100% (2) 
4.3.7 Statistical analysis 
All data were assessed and statistically analyzed using one-way ANOVA. All data are presented as 
mean±S.D. of at least three parallel groups (n≥3). *p≤0.05, **p≤0.01, as shown in the figure legends. p-Values 
≤0.05 and ≤0.01 indicate significant and highly significant differences. 
4.4 Materials and methods 
4.4.1 TiO2-PEG NPs inhibit cell migration in a size dependent manner  
Determining the effect of NPs on cell migration is vital to understanding the biological effects of NPs. It 
has been reported that NPs adversely affect cell migration. [32],[33] However, the molecular mechanism of 
cell migration inhibition by NPs is not well understood. Therefore, this work examined the effects of various 
sizes of TiO2 NPs on cell migration. Fig. 4.1A shows images from the scratch assay, where a monolayer of 
cells was scratched with p200 pipet tips. The colors in figure 4.1A were adjusted using adobe illustrator 2017 
cc software to increase the contrast ratio. After a 3 h incubation in the absence or presence of NPs, the distance 
between the edges of scratches was measured. The control group (without NPs) showed a narrower scratch 
width compared to the groups exposed to NPs. In addition, the inhibition of cell migration was proportional to 
the size of the NPs. To further study the effects of NPs on cell migration, the migration indexes were calculated 
(Figure 4.1B). Quantification of cell scratch changing confirmed that cell migration is significantly inhibited 
by NPs. Furthermore, larger NPs had the greatest inhibitory effect on cell migration. Therefore, our results 
showed that TiO2-PEG NPs size-dependently inhibited cell migration. 
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Figure 4.1 TiO2-PEG NPs inhibit cell migration in a size dependent manner. NCI-H292 cells were seeded 
overnight prior to the creation of scratches with p200 pipet tips. The cells were then exposed to TiO2-PEG NPs 
(100, 200, and 300 nm) at a concentration of 100 µg/mL for 3 h. (A) Scratch width changes with or without 
NP exposure, scale bar: 100 µm; (B) Quantification of cell migration with or without NP exposure. All data 
are displayed as mean±S.D. with at least three parallel groups and were analyzed using one-way ANOVA. 
*p≤0.05, **p≤0.01. 
4.4.2 Expression of integrin beta 1 is decreased by NPs 
Exposure to NPs not only causes stress to cell membranes and damages cellular integrity, but also damages 
the cytoskeleton and cell functions such as cell motility. [31],[34],[35] Therefore, we determined cellular 
uptake ratios of TiO2-PEG NPs after co-incubation with cells for 3 h. As displayed in figure 4.2A, the cellular 
uptake ratios of NPs significantly increased in a manner that was proportional to the size of NPs, similar to the 
observed effect on cell migration. The results suggest that the molecular mechanism of inhibited cell migration 
by NPs could be related to cellular uptake of NPs. 
Focal adhesions play vital roles in cell migration, which requires endocytosis and recycling of integrins. 
Endocytic integrin beta 1 is sorted from the early endosome and directed to either late endosomes and 
lysosomes for degradation or recycling endosomes and the plasma membrane for assembly into new focal 
adhesions. [36] In addition, the trafficking of integrin beta 1 can be achieved through clathrin-dependent 
endocytosis and clathrin-independent endocytosis (caveolin-dependent endocytosis and macropinocytosis), 
[24] which are the endocytic pathways utilized by TiO2-PEG NPs. [28] One-hundred and 300 nm NPs are 
initially internalized through clathrin-mediated endocytosis and macropinocytosis and then separately 
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transferred to early endosomes and macropinosomes, finally being localized to the lysosomes. Two-hundred 
nanometer NPs are internalized through both clathrin-mediated endocytosis and micropinocytosis and 
transferred to early endosomes and macropinosomes and finally lysosomes. Early endosomes and 
macropinosomes can be marked using the EEA1 antibody [37] and lysosomes can be marked using the LAMP1 
antibody. Therefore, to confirm the involvement of integrin beta 1 in the endocytosis of NPs, we tracked the 
localization of integrin beta 1, early endosome/macropinosome or lysosomes and NPs at 3 h. As shown in 
figure 4.2B, early endosomes and macropinosomes were labeled by the EEA1 antibody in blue, integrin beta 
1 was labeled with the anti-integrin beta 1 antibody in red and TiO2-PEG NPs were labeled by FITC in green. 
Additionally, bright field (BF) images were obtained to visualize the localization of cell structures. Firstly, the 
role of NPs during the endocytic process of integrin beta 1 was studied. As shown in merge 1 (figure 4.2B), 
integrin beta 1 was found to combine with NPs, as directed by the white arrows. Following that, more combined 
NPs with integrin beta 1 were found in the EEA1-positive endosomes compared with the control (merge 2, 
figure 4.2B), indicating promoted endocytosis of integrin beta 1 by NPs. Thereafter, the lysosomes, integrin 
beta 1 and NPs were tracked at 3 h (figure 4.2C). In the control group, the integrin beta 1 and lysosome loops 
were co-localized as indicated by the white arrows in the merged figure (merge 2, figure 4.2C), indicating the 
occurrence of lysosomal degradation of integrin beta 1 under normal conditions. After incubation with NPs for 
3 h, the combining of NPs with integrin beta 1 was also found in merge 1 (white arrows, figure 4.2C), and the 
lysosome loops increased compared to control cells. Additionally, FITC-labeled NPs were found to be 
encapsulated in twos or threes together by the lysosomal loops, and integrin beta 1 were distributed on or inside 
the lysosomes loops with NPs, as indicated by the white arrows. With larger NPs, more integrin beta 1 receptors 
were encapsulated with NPs by the lysosomes loops. Therefore, the localization analysis in figure 4.2B and 
4.2C indicates that endocytosis of integrin beta 1 is promoted through the combining of NPs with integrin beta 
1 and then translocated to lysosomes. Furthermore, expression of integrin beta 1 was significantly decreased 
after exposure to NPs (figure 4.2D), compared with control cells. Moreover, the expression of integrin beta 1 
following treatment with 300 nm NPs was lower than that of cells treated with 100 and 200 nm NPs, which 
suggests that the size of NPs affects endocytic pathways of NPs and integrin beta 1 and thereby integrin beta 
1 expression. The results showed that the decreased expression of integrin beta 1 observed in the cytoplasm is 
probably caused by lysosomal degradation. Therefore, the quantification and co-localization results suggest 
that the combining of NPs with integrin beta 1 promotes endocytosis of integrin beta 1 and translocation to 
lysosome for degradation, thereby leading to decreased the expression of integrin beta 1. 
In normal conditions, the balance with the lysosomal and recycling integrin beta 1 maintains the normal 
cell migration. When the balance of integrin beta 1 was damaged, the cell migration would be affected. Our 
work showed the decreased expression of integrin beta 1 with a size-dependent manner after NPs exposure. 
Therefore, to confirm the effects of NPs-mediated lysosomal integrin beta 1, the ratios of lysosomal integrin 
beta 1 was counted and displayed in figure 4.3. The result showed that after NPs’ exposure, the lysosomal 
integrin beta 1 increased significantly compared with the control. Besides that, larger NPs induced more 
integrin beta 1 to lysosomes. Therefore, based on above work, our work showed that the decreased expression 
of integrin beta 1 was mediated by NPs, which misrouted more integrin beta 1 to lysosome and thereby 
decreased its expression. 
4.4.3 Expression of pFAK is decreased by NPs 
FAK is a member of a family of non-receptor protein-tyrosine kinases that regulate integrin and growth 
factor signaling pathways involved in cell migration, proliferation, and survival. [38] In addition, FAK is one 
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of the first downstream signaling components to become activated by integrins. Based on the observed 
decrease in integrin beta 1 expression, the expression of pFAK was determined using flow cytometry. As shown 
in figure 4.4, pFAK expression was quantified after TiO2-PEG NP exposure for 3 h. The results showed that 
pFAK expression was significantly decreased following exposure to 100 to 300 nm TiO2-PEG NPs. This 
indicates that pFAK expression was decreased by NPs. 
4.4.4 F-actin structures are de-bundled and disrupted after NPs treatment 
During migration, a cell first extends protrusions (lamellipodia and filopodia), forms adhesions, and 
finally retracts its tail. The actin cytoskeleton plays a major role in this process. [39] pFAK modulates F-actin 
dynamics, including actin cytoskeleton polymerization and lamellipodia protrusion, and loss of pFAK reduces 
the maintenance of the integrity of bundled actin filaments. [40],[41] Based on the observed decrease in pFAK 
expression, F-actin expression after NP exposure for 3 hours was assessed by flow cytometry (figure 4.5A). 
Compared with control cells, F-actin expression was significantly decreased after exposure to NPs for 3 hours. 
Again, the effect was proportional to the size of the NPs, with F-actin expression significantly decreased 
between the cells treated with 100 and 300 nm NPs. Furthermore, the localization of pFAK (green) and F-actin 
(red) was observed by confocal microscope (figure 4.5B). In the control cells, pFAK was localized at the edge 
of the cell membrane and F-actin was bundled with lamellipodia and filopodia protrusions which were 
connected with pFAK. After treatment with NPs for 3 hours, F-actin was de-bundled and disrupted, and cells 
lacked protrusions, indicating that cellular motility would be decreased. Consistent with previous observations, 
more F-actin structures were fragmented by larger NPs.  
pFAK could sustain the stability of the lamellipodia protrusions of f-actin through combining with them. 
With the decreased expression of pFAK, the combining became unstable, leading to the disrupted f-action and 
adverse effect to cell migration. Therefore, the results suggest that the decreased pFAK expression de-bundled 
F-actin and disrupted the cellular cytoskeleton. 
Our results showed that the expression of F-actin was significantly decreased and F-actin structures were 
de-bundled and disrupted after NP exposure, which accounted for the inhibition of cell migration. 
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Figure 4.2 Integrin beta 1 is transferred from early endosome/macropinosomes to lysosomes with TiO2-
PEG NPs. Cells were seeded and exposed to the TiO2-PEG NPs (100, 200, and 300 nm) at a concentration of 
100 µg/mL for 3 h. (A) Quantification of cellular uptake ratios by flow cytometry; (B) Co-localization of 
integrin beta 1 with FITC-TiO2-PEG NPs in early endosomes and macropinosomes; (C) Co-localization of 
integrin beta 1 with FITC-TiO2-PEG NPs in lysosomes; (D) Quantification of changes in integrin beta 1 
expression. All data are displayed as mean±S.D. with at least three parallel groups and were analyzed using 
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one-way ANOVA. *p≤0.05, **p≤0.01. 
 
 
Figure 4.3 Ratios of lysosomal integrin beta 1 with or without NPs exposure. Cells were seeded and 
exposed to the TiO2-PEG NPs (100, 200, and 300 nm) at a concentration of 100 µg/mL for 3 h. After 
observation by confocal microscope, the numbers of lysosomes, lysosomal integrin beta 1, and lysosomal 
integrin beta 1 with NPs were counted and calculated as shown above. For each group, five cells were selected 
for counting and calculation. All data are displayed as mean±S.D. with at least three parallel groups and were 
analyzed using one-way ANOVA. *p≤0.05, **p≤0.01. 
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Figure 4.4 Quantification of pFAK. Cells were seeded and exposed to the TiO2-PEG or FITC-TiO2-PEG 
NPs (100, 200, and 300 nm) at a concentration of 100 µg/mL for 3 h. All data are displayed as mean±S.D. with 
at least three parallel groups and were analyzed using one-way ANOVA. *p≤0.05, **p≤0.01. 
 
Figure 4.5 Expression and localization of F-actin. Cells were seeded and exposed to the TiO2-PEG NPs 
(100, 200, and 300 nm) at a concentration of 100 µg/mL for 3 h. (A) Quantification of f-actin expression; (B) 
Localization and structural assessment of f-actin and pFAK. All data are displayed as mean±S.D. with at least 
three parallel groups and were analyzed using one-way ANOVA. *p≤0.05, **p≤0.01. 
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4.5 Discussion 
Integrin beta 1, as the major fibronectin receptor on most cells, transmit cellular signaling across cell 
membrane to modulate cell adhesion, survival and migration. Its endocytic trafficking is divided into two parts 
based on the trafficking time: one is long loop trafficking during which integrin beta 1 is recycled to the plasma 
membrane for new focal adhesions formation and cell migration; the other one is short loop trafficking during 
which integrin beta 1 is sorted and translocated to the late endosome or lysosome for degradation. [42] The 
equilibrium between recycling and degradation of integrin beta 1 maintains the normal cell migration, which 
plays a crucial part in embryo development, histogenesis, and wound healing. [43]  
However, exposure of NPs struck the balance of integrin beta 1, as they share the same endocytic 
pathways but different exocytosis pathways. [44,45] NPs, after endocytosis into cytoplasm, partly remain in 
the cells for a long time, such as macrophage, or are transferred outside of cytoplasm through exocytosis, 
including lysosomes, multivesicular bodies, and other pathways. [45] In our work, following NPs exposure for 
3 h, more integrin beta 1 was found firstly in EEA1-positive endosomes and then lysosomes compared with 
control (no NPs exposurs). Furthermore, insides of both endosomes, NPs were found to combine with integrin 
beta 1. These results indicate that NPs firstly combined with integrin beta 1 at the beginning of endocytosis, 
and then the combination of NPs and integrin beta 1 was internalized through corresponding pathways which 
were dependent on sizes of NPs. Therefore, NPs triggered and promoted the endocytosis of integrin beta 1. 
Following that, endocytic combination of NPs and integrin beta 1 was sorted and translocated to lysosome, 
which probably decreased the expression of integrin beta 1 through lysosomal degradation. This misrouting of 
integrin beta 1 to the degradation pathway (lysosomes) rather than recycling pathways reduced cell spreading 
on fibronectin. [46] However, the lysosomal integrin beta 1 could be promoted to recycling from late 
endosomes or lysosomes by Rab25 and CLIC3 to drive cancer progression. [47] Therefore, during the 
trafficking of integrin beta 1 with NPs, if such recycling proteins participant and promoted the cycling of 
integrin beta 1 to plasma membrane, it still needs more work to confirm. pFAK is important for cell 
migration, as It could integrate growth factor and integrin signals to promote cell migration, [48] and 
expression of the protein-tyrosine phosphatase (PTEN) induces dephosphorylation of FAK and inhibition of 
cell migration. [49] Experiments using FAK-null cells, overexpression of FAK enchanced cell spreading and 
migration. [50,51] While, cultured FAK deficient cells display a rounded morphology, increased formation of 
cell-substratum contact sites and migration defects. [51] pFAK, as the transduction signaling of cell migration, 
is activated by integrins. So, less expression of integrin beta 1 reduced the activation of pFAK, leading to 
weaker signaling of cell migration. Besides that, pFAK could maintain the stability of protrusions (lamellipodia 
and filopodia) of f-actin to modulate cell migration. [40,41,52] Therefore, when the expression of pFAK was 
decreased, the integrity of bundled actin filaments was also damaged, which deceased the polarity of cell and 
thereby cell migration. 
Therefore, our work studied the cytotoxicity of NPs from the integrin beta 1-mediated inhibition of cell 
migration. And larger NPs significantly decreased cell migration. This work provides information on the cancer 
therapy through inhibiting cancer invasion by targeting integrin beta 1 to degradation routing. 
4.6 Conclusions 
Migration of NCI-H292 cells was inhibited by TiO2-PEG NPs, which was mediated by integrin beta 1. 
The possible mechanism of integrin-mediated inhibition of cell migration is displayed in figure 4.6. The 
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combining of NPs with integrin beta 1 promoted the endocytosis of integrin beta 1 from EEA 1-positive 
endosomes to lysosomal degradation, which decreased the expression of integrin beta 1. Following that, pFAK 
expression was decreased due to the reduced activation from upstream integrin beta 1, which weakened the 
binding between pFAK and f-actin and led to de-bundled and disrupted f-actin structure, thereafter inhibiting 
cell migration. Furthermore, size of NPs played an important role in cellular uptake pathways and ratios. The 
larger NPs in our work possessed higher cellular uptake ratios, which significantly inhibited cell migration 
through decreasing the expression of integrin beta 1, pFAK, and f-actin. Therefore, cell migration is relative 
to not only surface receptor, integrin beta 1, but also sizes of NPs, which provides valuable information for 
cancer therapy by NPs-mediated integrin beta 1. 
 
 
Figure 4.6 Schematic of the possible mechanisms of the inhibition of cell migration caused by NPs via 
integrin beta 1. Without NPs exposure, the structure, localization and function of integrin beta 1, pFAK and 
actin were normal, which maintain the normal cell migration. After NPs’ exposure, NPs firstly binded with the 
integrin beta 1, which promoted and misrouted more integrin beta 1 to lysosomes and thereby decreased the 
expression of integrin beta 1. Following that, because of the decreased activation from integrin beta 1, the 
expression of pFAK was decreased, which damaged the maintenance of bundled actin structure and inhibited 
cell migration. 
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5.1 Concluding remarks  
 
 
This work focused on the effects of TiO2 NPs with different doses and sizes to cellular responses for improving 
the safety usage of TiO2 NPs in our daily life. Firstly, the TiO2 NPs with or without PEG surface modification 
were prepared to study the doses and cytotoxicity. Secondly, the uniform TiO2 NPs with PEG coating were 
prepared with the sizes of 100, 200, and 300 nm to study the relationship between sizes and cytotoxicity. Finally, 
our work showed the possibility to improve safety of NPs through controlling doses and parameters, as shown 
in figure 4.1. 
 
Chapter 1 introduced the several nanomaterials and their safety concerns, including TiO2, aluminum oxide, 
gold, zinc oxide, iron oxide, carbon, and silica nanomaterials. Then the common endocytosis and exocytosis 
pathways of nanomaterials were introduced, such as clathrin-dependent endocytosis, macropinocytosis, and 
exocytosis, which were related to NPs in our following work. Then cellular responses including proliferation 
and apoptosis were introduced from the signaling pathways and detection methods. Following that, cell 
migration was introduced. Finally, the aims of work were displayed and divided into two parts.  
 
Chapter 2 displayed the cellular effects of TiO2 NPs with or without PEG coating to HepG2 cells. The 
results showed that cell death was induced at the high doses’ exposure of NPs, which cell growth increased at 
low doses of TiO2-PEG NPs. After that, cell growth was proved through cell number counting and cell cycle 
detection. Then the molecular mechanism about cell proliferation at low dose of TiO2-PEG NPs was studied, 
suggesting the aggregated HGFRs by the extracellular TiO2-PEG NPs were the reason of cell proliferation. 
Finally, our results showed that even low doses of NPs could cause cellular responses, showing high cell 
viability not equal to safety of NPs. Besides that, through controlling the doses of NPs, the safety usage could 
be achieved. 
 
Chapter 3 showed the apoptosis of NCI-H292 cells induced by uniform TiO2-PEG NPs with the size of 
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100, 200, and 300 nm. Firstly, uniform NPs with different sizes were prepared by sol-gel methods. Then size 
stability of uniform NPs was studied by dispersing them into cell culture medium with 10% HFBS to compare 
the sizes changes before and after 24 hours’ storage. The results showed NPs owned stable sizes in cell culture 
medium. After that, NPs were used to study the cell viability, showing size-dependent decreasing of cell 
viability with the increase of NPs’ sizes. After that, cell apoptosis was checked, displaying size-dependent 
increase. To confirm the apoptosis, the activities of caspase 3 were detected, the results of which also showed 
a size-dependent increase. Therefore, the results confirmed that larger NPs caused higher apoptosis. Then the 
mechanisms of size-dependent apoptosis were studied from cellular uptake and relative pathways. The results 
showed that sizes of NPs determined how NPs were internalized by cell, which thereby determined the cellular 
uptake ratios. The different endocytic NPs activated size-dependent caspase 3 activities, thereby inducing size-
dependent apoptosis. Therefore, our work showed that larger NPs caused a higher apoptosis, which was 
determined by the sizes of NPs. Our work is potential to provide useful information to improve the safely 
usage of NPs by controlling sizes of NPs. 
 
Chapter 4 showed the size-dependent inhibition of cell migration after NPs exposure with the sizes of 100, 
200 and 300 nm. Firstly, cell migration with or without NPs exposure was measured through the scratches 
creating, showing the size-dependent inhibition of cell migration with the increase of NPs’ sizes. Then cellular 
uptake ratios were detected, showing higher NPs owning higher cellular uptake ratios. The above results gave 
one inspiration that the inhibition of cell migration happened in the cytoplasm. Therefore, to know the 
mechanisms of inhibited cell migration, three important molecules were chosen. They were integrin beta 1, 
FAK and actin, because integrin beta 1 could activate FAK, then the activated FAK (pFAK) control the 
structure of actin, thereby controlling cell migration. The three molecules were quantified and observed by 
flow cytometer and confocal microscopy separately. The results showed size-dependent decrease of integrin 
beta 1, FAK and actin. To further study the reason of decreased expression of integrin beta 1, the NPs with 
integrin beta1 in EEA1-positive endosomes and macropinosomes were observed, finding the co-localization 
of integrin beta 1 and NPs in both two kinds of endosomes. Besides that, overlay of integrin beta 1 and NPs 
was observed, indicating the binding of integrin beta 1 and NPs. Therefore, our work suggested the binding of 
integrin beta 1 and NPs misrouted more integrin beta 1 to lysosomes, which decreased expression of integrin 
beta 1. As FAK was activated by integrin beta 1, expression of pFAK was expected to be decreased. Following 
that, pFAK expression was checked by flow cytometer, showing decreasing in a size-dependent manner. Finally, 
the expression and structure of actin was quantified and observed, showing size-dependent decrease of 
expression and structure damages, suggesting inhibited cell migration in a size-dependent manner. Therefore, 
our work suggested the size-dependent inhibition of cell migration was via integrin beta 1. 
 
In conclusion, our work provides helpful information for the safety usage of NPs in our daily life through 
controlling doses and sizes of NPs. Furthermore, from the doses study of NP, our work showed that high cell 
viability does not mean NPs are safe to human. More detailed work showed be carried on to get the all-faced 
data about cellular responses to block the side effects of NPs, thereby improve their safety. 
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Figure 5.1 The conclusions of our work. Our work gave answers to two questions as put forward at the 
beginning. Firstly, high cell viability is not equal to the safety usage of NPs as even at the low doses exposure 
of NPs, abnormal cellular responses could be induced, which is very harmful when applied to the cancer cells. 
Then, it is possible to improve the safety of NPs through controlling the sizes and doses of NPs, which gave 
the insight that NPs safety could be improved by optimizing the parameters of NPs. 
5.2 Prospects 
 
 
In this work, two parameters (doses and sizes) of TiO2 NPs were studied to improve the safety of NPs. 
Except those, other parameters, such as shape, surface charges and morphology could be studied. Furthermore, 
more kinds of cells could be chosen, such as stem cells to study the effects on differentiation, macrophage cells 
to study the effects on cellular uptake and inflammation and so on. Based on the basic toxicity or cellular 
response studies, safety of NPs was expected to be improved for future application in the drug delivery system, 
tissue engineering and other fields. 
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Figure 5.2 The prospects of future work and possible applications of NPs. Future work could be started 
from the study of other parameters effects on cellular responses. Through these work, more information could 
be obtained to improve the properties of NPs, which establish the basis for future application of NPs, such as 
medical application and tissue engineering. 
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